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ABSTRACT 
A diet rich in fruits and vegetables has been suggested to decrease the risk of 
colorectal cancer and the protective effects of these foods could probably be at 
least partly mediated by their polyphenolic compounds. The number of 
different polyphenols is huge and their effects on cells and tissues may differ. 
The promising results on chemopreventive effects of ellagitannin-rich 
pomegranate suggest that the other dietary sources of ellagitannins may also 
be effective in cancer prevention. 
 
The overall aim of the research reported in this thesis was to study the effects 
of cloudberry (Rubus chamaemorus), which is rich in ellagitannins, on all 
phases of intestinal tumour development. Specifically, the effects of 
cloudberry on the first two phases of carcinogenesis, initiation and promotion, 
were studied using the ApcMin mouse model. In addition, the effects of 
cloudberry extract on the indicators of the last phase of cancer development, 
progression and metastasis, and particularly cancer cell migration that is 
essential for this phase, were studied using scattering and wound healing 
assays in hepatocyte growth factor-induced HT29 and HCA7 human colon 
adenocarcinoma cell lines. 
 
A whole-cloudberry diet containing 10% (w/w) freeze-dried cloudberries 
significantly decreased the number and size of intestinal adenomas in ApcMin 
mice. In contrast, cloudberry seeds, cloudberry pulp, or pure ellagic acid, when 
incorporated into the diets in concentrations that corresponded to the whole-
cloudberry diet, had no apparent effect. The effects of cloudberry on the 
development of adenomas were also compared with the effects of bilberry 
(Vaccinium myrtillus), which is rich in anthocyanins. Both berries decreased 
the number of adenomas, but their effects of adenoma size were different: 
thus, the adenoma size was decreased by cloudberry and increased by bilberry 
in comparison to the control diet. The opposite effects of the berries on tumour 
growth were associated with the changes in the gut microbiota, intestinal 
immunity, and the expression of energy metabolism-related genes. 
 
The activation of Met, which is also known as hepatocyte growth factor 
receptor induces cell migration and is considered to play an important role in 
tumour metastasis. Cloudberry extract inhibited cell migration by inhibiting 
the activation of Met in hepatocyte growth factor-induced human HT29 and 
HCA7 colon adenocarcinoma cells, and thus Met signalling and consequent 
activation of the phosphatidylinositol 3-kinase/AKT pathway. The activation 
of Met signalling in the tumours of cloudberry-fed ApcMin mice was also 
inhibited. 
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The results of the research presented in this thesis suggest that consumption 
of cloudberry or cloudberry preparations may reduce the risk of colon cancer, 
slow down the growth of colon adenomas, and have therapeutic value in 
reducing cancer progression and metastasis. Long-term studies in human 
subjects are needed to confirm these results.     
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1 Introduction 
Colorectal cancer is the third most common cancer type worldwide, the second 
most common after breast cancer in women and the third most common after 
lung and prostate cancers in men. Regional differences are enormous: in 2012, 
the highest age-standardised incidence rates for colorectal cancer were in 
Oceania (34.8/100 000/year) and in Europe (29.5), and the lowest (4.1) in 
Western Africa (IARC 2012). The incidence rate for colorectal cancer in 
Finland was 17.0/100 000/year for men and 13.4/100 000/year for women in 
2014. However, the incidences for both genders were higher in Southern 
Finland than in Northern Finland (Pukkala and Patama 2010). The regional 
differences, both worldwide and in Finland, are assumed to be the result from 
the differences in diet and other lifestyle factors. 
 
Since dietary constituents and their metabolites are in direct contact with the 
digestive tract, the tissues of the digestive tract are susceptible to both cancer-
preventive and cancer-promoting effects of the diet. Furthermore, diets rich in 
fruits and vegetables are suggested to decrease the risk of colorectal cancer 
(WCRF/AICR 2011). The beneficial effects of these foods may at least partly be 
explained by their various polyphenolic compounds, and the mechanisms that 
mediate their effects on the intestinal mucosa have been studied intensively 
since the beginning of 2000s (Brown et al. 2012, Little et al. 2015, Macdonald 
and Wagner 2012). However, the molecular mechanisms are numerous and 
complex, and are still not known in detail. Since many of the polyphenols are 
antioxidants in vitro (Manganaris et al. 2014), they were initially thought to 
protect cells from mutations that lead to malignant transformation by 
inhibiting oxidative reactions (Stevenson and Hurst 2007). Today it is known 
that they probably prevent carcinogenesis through several mechanisms 
including antiproliferative, proapoptotic, antiangiogenic and anti-
inflammatory effects (Afrin et al. 2016, Fresco et al. 2010). Furthermore, due 
to their limited absorption in the upper gastrointestinal tract, many 
polyphenols end up to the colon and are metabolized by gut microbiota 
(Tomás-Barberán et al. 2016). The metabolites of polyphenols formed may be 
more bioavailable than the original polyphenols they were derived from and 
probably mediate some of the beneficial effects of polyphenols (Williamson 
and Clifford 2010). This possible mechanism therefore makes the entire 
cancer reducing effect of polyphenols even more complex to describe. Thus, 
polyphenols may affect gut health in the form they were ingested, as 
intermediate metabolites and/or degradation products produced in the 
stomach and/or in the small intestine, and/or as metabolites produced by 
colonic microbiota. In addition, colorectal cancer is known to develop through 
several phases (Fodde et al. 2001), and the polyphenols are likely to affect all 
of them (Surh 2003). 
Introduction 
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Many epidemiological studies suggest that diets rich in fruits and vegetables 
reduce the risk of colorectal cancer (Song et al. 2015). Experimental studies on 
the anti-carcinogenic effects of some berries, such as black raspberry and 
strawberry, have been published so far, but the effects of Finnish wild berries 
have not been studied in in vivo cancer models. In addition, pomegranate, 
which is rich in ellagitannins has been shown to exhibit anti-carcinogenic and 
anti-inflammatory properties both in in vitro and in vivo models, but 
chemopreventive effects of ellagitannin-rich cloudberry have so far been 
studied in only two in vitro studies (Wu et al. 2007, McDougall et al. 2008). 
 
The research done for this thesis focuses on the chemopreventive effects of 
cloudberry, a rich source of ellagitannins, in the experimental models of colon 
cancer, and the effects of anthocyanin-rich bilberry are used as a reference for 
comparison purposes. The aims of the studies I–III were to investigate the 
effects of cloudberry and its components on the first two steps of 
carcinogenesis, initiation and promotion, in the ApcMin mouse. Study IV aimed 
to explore the third step of carcinogenesis, progression, in hepatocyte growth 
factor-induced colon adenocarcinoma cells. Inhibiting all three steps of cancer 
development by dietary means may help to decrease both the incidence and 
mortality of colon cancer. 
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2 Colon carcinogenesis and the ApcMin 
mouse as an experimental model 
2.1 Colon carcinogenesis 
A majority (70%) of colorectal cancers develop sporadically, i.e. without any 
inherited predisposition to cancer. However, 20-30% of cases have a familial 
background, and approximately 5% are explained by highly penetrant 
inherited mutations (Jasperson et al. 2010, Hahn et al. 2016). Lynch 
syndrome is characterised by defects in DNA mismatch repair genes and 
accounts for 2-4% of all colorectal cancers (Jasperson et al. 2010), whereas 
familial adenomatous polyposis (FAP) with a germline mutation in APC 
tumour-suppressor gene accounts for 0.5% of all colorectal cancers (Hahn et 
al. 2016, Fearon et al. 2011). However, it has been estimated that 70-80% of 
sporadic colorectal tumours also have inactivating somatic mutations in the 
APC gene. The gene is referred to as a gatekeeper gene and the inactivation of 
this gene, which probably occurs in the intestinal stem cells, leads to genetic 
instability and thus the accumulation of additional mutations, activating 
oncogenes and inactivating tumour-suppressor genes. These all act in concert 
and result in tumour development (Fodde et al. 2001, Vermeulen and Snippert 
2014). The development of colorectal cancer proceeds through a well-defined 
adenoma-carcinoma sequence and it is unlikely to start without the initial APC 
mutation (Fearon and Vogelstein 1990, Fearon 2011). 
  
A normal cell first becomes mutated and changed to an initiated cell in the 
initiation phase. In the case of the APC gene, heterozygous mutation with one 
mutated and the other wild-type allele will still maintain histologically normal 
tissue, whereas a mutation in the other allele leads to the loss of heterozygosity 
(LOH), which in turn leads to the activation of the Wnt signalling pathway, 
increased cell division (proliferation) and the development of early adenoma 
(Fodde et al. 2001). In the promotion phase, the adenoma grows bigger and 
becomes more malignant as a result of accumulating mutations in tumour-
suppressor genes and proto-oncogenes. This in turn, leads to the activation of 
various signalling pathways including phosphatidylinositol 3-kinase 
(PI3K)/AKT, mitogen-activated kinase (MAPK), and nuclear factor κB (NF-
κB) pathways (Dammann et al. 2014). In addition to increased proliferation, 
programmed cell death (apoptosis) in tumours is decreased and the imbalance 
between proliferation and apoptosis promotes tumour growth. Blood supply 
in growing tumours is guaranteed by increased formation of new blood vessels 
(angiogenesis). In the last phase of tumourigenesis, progression, the 
carcinoma invades to the surrounding tissues and forms metastases due to the 
migration of cancer cells and the breakdown of the extracellular matrix 
Colon carcinogenesis and the ApcMin mouse as an experimental model 
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(Fearon 2011). The steps of colon cancer development with the most essential 
molecular changes and signalling pathways studied in this thesis are presented 
in Figure 1.  
 
 
 
Figure 1.  The development of colorectal cancer through a multistep process. The adenoma-
carcinoma sequence proceeds from normal epithelium and ends in carcinoma and 
metastases. This process is mediated by the inactivation of tumour-suppressor 
genes such as APC (adenomatous polyposis coli), DCC (deleted in colorectal 
carcinoma) gene, SMAD, and P53, and by the activation of proto-oncogenes, e.g. 
K-RAS. The activation of HGF/Met signalling is characteristic for the last phase of 
carcinogenesis but may also be present in the previous phases (Modified based on 
Fearon 2011; Dammann et al. 2014, Trusolino et al. 2010).   
 
2.2 The ApcMin mouse  
The ApcMin mouse strain (Min, multiple intestinal neoplasia) is the most 
widely used animal model for studying human familial adenomatous polyposis 
(FAP). Because the molecular mechanisms of tumour development are similar 
in the ApcMin mouse and in human sporadic colon tumourigenesis, it is also 
used as a model for sporadic colon cancer. This mouse strain was originally 
established by exposing C57BL/6J mice to the chemical carcinogen, 
ethylnitrosourea, after which some of the progeny of these mice were found to 
develop multiple adenomas in the small intestine and to carry a heterozygous 
dominant mutation in the Apc gene, which is the mouse homolog for the 
human APC gene (Moser et al. 1990). The nonsense mutation at codon 850 
causes the mutated Apc allele, which results in the formation of a truncated 
form of the Apc protein. However, the full-length protein coded by the non-
mutated, wild-type allele will still prevent the activation of Wnt signalling and 
dysregulated cell proliferation. Mutation in the Apc gatekeeper gene makes the 
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cell susceptible to additional mutations, and a mutation of the wild-type Apc 
allele leads to tumour development (Moser et al. 1995). ApcMin mice on a 
C57BL/6J background usually develop between 30 to 50 adenomas in the 
small intestine, and less than one tumour per animal in the colon. The tumours 
are benign in the mouse model and do not become invasive, presumably due 
to the short lifespan of ApcMin mice, which is 150 days at the most (Moser et 
al. 1995, Bilger et al. 1996). 
 
Tumour development in ApcMin mice results from the accumulation of β-
catenin in the cytoplasm and the nucleus of intestinal epithelial cells, which 
leads to an aberrant activation of β-catenin-dependent Wnt signalling 
pathway. The amount of free β-catenin in the cytoplasm of normal cells is 
tightly regulated by the destruction complex, which is formed by Apc and other 
proteins, such as glycogen synthase kinase 3β, axin, and casein kinase 1α. The 
complex phosphorylates β-catenin and thereby targets it for ubiquitination 
and subsequent proteasomal degradation. The coordinated phosphorylation 
and destruction of β-catenin are disrupted in the cells that have a homozygous 
Apc mutation. Thus, β-catenin accumulates in the cytoplasm and translocates 
to the nucleus, where it participates in activating the expression of genes that 
enhance cell proliferation, e.g. c-myc and cyclin D1, and thus leads to the 
tumour development (Aoki and Taketo 2007).  
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3 Cloudberry, bilberry, their compounds 
and metabolites 
3.1 Cloudberry 
Cloudberry (Rubus chamaemorus) belongs to the Rubus genus and is closely 
related to raspberry (R. idaeus), blackberry (R. fruticosus), black raspberry 
(common name for R. leucodermis, R. occidentalis and R. coreanus), and 
arctic bramble (R. arcticus). As a member of the Rosaceae family it is also 
related to strawberry (Fragaria x ananassa). The Rubus and Fragaria berries 
are, in addition to pomegranate, certain nuts, and oak-aged wines, the most 
important dietary sources of ellagitannins, polyphenols that belong to the 
group of hydrolysable tannins (Koponen et al. 2007, Ovaskainen et al. 2008, 
Landete 2011). The content of ellagitannins in fresh cloudberries is more than 
300 mg/100 g (Koponen et al. 2007) and consists mainly of the dimeric 
sanguiin H-6 and the trimeric lambertianin C, but the monomeric 
pedunculagin also exists (Kähkönen et al. 2012; Fig. 2). In addition, 
cloudberry contains some free ellagic acid, hydroxycinnamic acids (p-
coumaric acid, caffeic acid, ferulic acid, sinapic acid), hydroxybenzoic acids 
(gallic acid, vanillic acid), flavan-3-ols, flavonols (quercetin), and 
proanthocyanidins (cyanidin) (Määttä-Riihinen et al. 2004, Mattila et al. 
2006). Lignans and small amounts of carotenoids, mainly β-carotene, also 
exist in cloudberries (Smeds et al. 2012, Lashmanova et al. 2012). However, 
ripe cloudberries contain no or negligible amounts of anthocyanins (Jaakkola 
et al. 2012, Koponen et al. 2007). 
   
Cloudberry contains large seeds, which make up 12% of its fresh weight 
(Johansson et al. 1997) and 47% of dry weight (Päivärinta et al. 2006). 
Cloudberry seeds contain large amounts of lignans, mainly medioresinol, 
lariciresinol, and syringaresinol (Smeds et al. 2012). The oil content of seeds 
is 12% of dry weight, whereas that of the fresh berries is 1.4% (Johansson et al. 
1997). The dominating fatty acids are linoleic acid (41%), α-linolenic acid 
(36%), and oleic acid (14%) (Johansson et al. 1997).  
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Figure 2.  Structures of the main ellagitannins of cloudberry: dimeric sanguiin H-6 (A), trimeric 
lambertianin C (B), and monomeric pedunculagin (C). Small amounts of free ellagic 
acid (D) are also found in cloudberries. 
Ellagitannins constitute a complex group of polyphenols with an enormous 
structural variability (Landete 2011). As hydrolysable tannins some of them 
release ellagic acid in the human stomach and/or the small intestine, but the 
efficiency of ellagic acid release may be different depending on the structure 
of ellagitannin. Pharmacokinetic studies have shown that raspberry 
ellagitannins (sanguiin H-10, sanguiin H-6, and lambertianin C) released 
ellagic acid more efficiently than pomegranate ellagitannin punicalagin 
(González-Barrio et al. 2010, González-Sarrías et al. 2015). Although small 
amounts of ellagic acid are absorbed in the stomach and in the proximal small 
intestine, and quickly eliminated from the blood (González-Barrio et al. 2010, 
Cloudberry, bilberry, their compounds and metabolites 
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Seeram et al. 2006b), ellagitannins are not absorbed intact (Espín et al. 2007). 
The majority of ellagitannins and ellagic acid reach the distal small intestine 
and colon, where they are metabolised to more bioavailable urolithins by gut 
microbiota (Fig. 3). Urolithins are absorbed, then metabolised in the liver and 
excreted in urine and bile. They also undergo active enterohepatic circulation 
along with the bile acids (Espín et al. 2007). Urolithins in mice accumulate in 
the colon, the small intestine, and the prostate (Seeram et al. 2007), and they 
have also been found in the prostate in humans (González-Sarrías et al. 2010). 
In vitro urolithins have been shown to inhibit cell proliferation in colon and 
prostate cancer cells (Kasimsetty et al. 2010, Cho et al. 2015, Seeram et al. 
2007).  
 
 
Figure 3.  Structures of the main microbial metabolites of ellagitannins and ellagic acid: 
urolithin A (A), urolithin B (B), and isourolithin A (C).  
 
3.2 Bilberry 
Bilberry, Vaccinium myrtillus, was used as the reference berry in the studies 
conducted for this thesis, due to its very different total polyphenol content in 
comparison to cloudberry: bilberry is rich in anthocyanins but contains no 
ellagitannins (Koponen et al. 2007). The total anthocyanin content in 
bilberries is approximately 610?800 mg/100 g of fresh weight (expressed as 
weight of aglycone moieties), of which around 35% delphinidin, 33% cyanidin, 
16% malvidin, 12% petunidin, and 4% peonidin (Määttä-Riihinen et al. 2004, 
Koponen et al. 2007). Bilberries also contain some hydroxycinnamic (p-
coumaric acid and caffeic or ferulic acids), flavonols (myricetin and quercetin), 
flavan-3-ols (mostly (-)-epicatechin), and proanthocyanidins (Määttä-
Riihinen et al. 2004).  
 
A proportion of anthocyanins is taken intact into the epithelial cells of the 
stomach and the small intestine, and metabolised in the cells before they enter 
the circulation, from which they are rapidly cleared (Fang 2014). However, the 
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total absorption of the anthocyanins is limited and thus most of anthocyanins 
reach the distal small intestine and the colon, where they are mainly 
metabolised to protocatechuic acid. In addition, smaller quantities of ferulic, 
syringic, gallic, vanillic, p-coumaric and caffeic acid have also been detected 
(Aura et al. 2005, de Ferrars et al. 2014, Fleschhut et al. 2006, Hidalgo et al. 
2012, Vitaglione et al. 2007). 
  
The nutritional compositions of cloudberry and bilberry are similar except for 
the concentration of insoluble fibre, which in cloudberries is 5.8 g/100 g of 
fresh weight and in bilberries 2.6 g/100 g. The concentration of soluble fibre 
in both berries is 0.5 g/100 g of fresh weight (National Institute for Health and 
Welfare 2017, www.fineli.fi). 
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4 Experimental evidence of ellagitannin and 
anthocyanin-containing berries in 
gastrointestinal cancer chemoprevention 
4.1 In vitro studies 
The effects of ellagitannin-containing berries and ellagic acid have been 
investigated in many cell lines, and the results of in vitro studies using 
gastrointestinal cells are reviewed in Table 1. The studies are presented 
chronologically in order to show the progress of the research. Most studies 
have focused on berries containing both ellagitannins and anthocyanins, e.g. 
black raspberry, strawberry, and (red) raspberry, and there are only two 
studies that show the effects of cloudberry in cell cultures (McDougall et al. 
2008, Wu et al. 2007). All studies are not fully comparable due to the 
differences in the composition of berry extracts and their concentrations in cell 
culture medium. For example, a study on cloudberries by Wu et al. (2007) 
used whole-berry extracts, whereas McDougall et al. (2008) used polyphenol-
rich extracts from which sugars, organic acids, carotenoids, and vitamin C had 
been removed.  Whole-cloudberry extract inhibited cell growth in HT-29 colon 
carcinoma cells, and increased the mRNA expression of p21WAF1, an inhibitor 
of cell proliferation, as well as Bax, a promoter of apoptosis (Wu et al. 2007). 
Polyphenol-rich extracts of strawberry, arctic bramble and cloudberry reduced 
the viability of Caco-2 colon adenocarcinoma cells (McDougall et al. 2008). In 
conclusion, study results presented in Table 1 suggest that ellagitannin-
containing berry extracts and ellagic acid may inhibit cell proliferation and 
migration, induce apoptosis, attenuate inflammatory signalling and reduce 
oxidative damage in tumour cell cultures. However, since most berries contain 
both ellagitannins and anthocyanins, it remains unclear to what extent the 
effects are specific for ellagitannins per se.  
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Table 1. Summary of reviewed in vitro studies on the effects of ellagitannin and anthocyanin-
containing berry extracts or ellagic acid (EA) in human gastrointestinal* tumour cell cultures.     
Reference Cell line(s) Berries or compounds 
studied / Study design 
Main findings: the effects of 
berry extracts and EA on 
carcinogenesis 
Katsube et al. 
2003  
HCT116 colon 
carcinoma cells 
HL60 leukemia cells 
Extracts from raspberry, 
blackberry and strawberry at 
2 ̶ 6 mg dry wt/mL for 48 hrs 
Cell growth ↓ by all the berries in 
both cell lines; the mechanisms 
were not studied. 
Losso et al. 
2004 
Caco-2 colon 
adenocarcinoma cells 
HUVEC1 cells 
HEL 299 normal lung 
fibroblasts 
MCF-7 and Hs 578T 
breast cancer cells 
DU 145 prostate 
cancer cells 
Ellagic acid at 1 ̶ 100 μmol/L 
for six hours 
No effect on the viability of normal 
fibroblasts. Caco-2 were the most 
sensitive cells. Cell proliferation ↓, 
migration ↓ in all cancer cells. 
Apoptosis ↑, the activities of pro-
matrix metalloproteinases MMP-2 
and MMP-9 ↓, the levels of 
secreted vascular endothelial 
growth factor VEGF165 ↓. Tube 
formation in HUVEC cells ↓.  
Olsson et al. 
2004 
HT-29 colon 
adenocarcinoma cells  
MCF-7 breast cancer 
cells 
Raspberry extract at 0.025, 
0.05, 0.25, and 0.5% of plant 
dry wt/total wt for 24 hrs 
Proliferation dose-dependently ↓ 
in both cell lines. Correlation 
between the inhibitory effect and 
vitamin C levels in extracts; 
probably synergism between 
vitamin C and other compounds.  
Larrosa et al. 
2006 
Caco-2 colon 
adenocarcinoma cells 
CCD-112CoN normal 
colon cells 
(fibroblasts)  
Caco-2: EA at 1-30 μM, 
punicalagin (PUNI) at 1-100 
μM, and their mixtures (1 + 1 
μM, 10 + 10 μM) for 72 hrs; 
CCD-112CoN: EA at 30 μM 
and PUNI at 100 μM for 12 
days (media incl. EA and 
PUNI were replaced every 3 
days)  
Caco-2: Proliferation dose- and 
time-dependently ↓ by EA, 
punicalagin and their mixture (1 + 
1 μM, 10 + 10 μM); apoptosis ↑ 
(Bcl-xL ↓, activation of caspases 3 
and 9); cyclin A and B1 ↓, cyclin E 
↑; cell-cycle arrest in S phase. 
CCD-112CoN cells; no effect on 
apoptosis. 
Olsson et al. 
2006 
HT-29 colon 
adenocarcinoma cells  
MCF-7 breast cancer 
cells 
Extracts from organically or 
conventionally cultivated 
STR at 0.025%, 0.05%, 
0.25%, 0.5% (plant dry 
wt/total wt) for 24 hrs 
Proliferation ↓ by all STR extracts 
in both cell lines. For HT29 cells, 
a negative correlation between 
the content of ellagic acid and the 
extent of antiproliferation was 
found at 0.05% STR extract. 
Seeram et al. 
2006a 
HCT116 colon 
carcinoma cells 
HT-29 colon 
adenocarcinoma cells 
KB and CAL-27 oral 
tumour cells 
MCF-7 breast cancer 
cells  
LNCaP prostate 
carcinoma cells 
Blackberry (BlackB), BRB, 
BB, red raspberry (RRB) 
and strawberry (STR) 
extracts at 25 2̶00 μg/mL for 
48 hrs 
Proliferation dose-dependently ↓ 
in all each cell lines.  
In HT-29 cells, apoptosis ↑ by 
BRB and STR at 200 μg/mL; the 
pro-apoptotic effect of other 
berries was smaller. No effect on 
apoptosis. 
to be continued 
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Table 1 continues: Summary of reviewed in vitro studies on the effects of ellagitannin and 
anthocyanin-containing berry extracts or ellagic acid (EA) in human gastrointestinal* tumour cell 
cultures.      
Reference Cell line(s) Berries or compounds 
studied / Study design 
Main findings: the effects of 
berry extracts and EA on 
carcinogenesis 
Coates et al. 
2007 
HT-29 colon 
adenocarcinoma cells  
Caco-2 colon 
adenocarcinoma cells 
HT115 colon 
carcinoma cells 
Colon-available raspberry 
extract (CARE) prepared by 
subjecting the original 
extract to an in vitro 
digestive process; at several 
concentrations ranging 
between 0 ̶ 50 μg/ml for 24 ̶ 
48 hrs 
HT-29: H2O2-induced DNA 
damage ↓, the number of cells in 
G0/G1 phase of cell cycle ↓ 
HT115: invasion in Matrigel 
invasion assay ↓ 
Caco-2: no effect on barrier 
function of the monolayer. 
Wu et al. 2007 HT-29 colon 
carcinoma cells 
Cloudberry (CB), STR, and 
RB extracts at 0-60 mg/mL 
for 24 hrs for the 
proliferation assay and RNA 
extraction, and for 48 hrs for 
the DNA fragmentation 
assay 
CB extract: 40% ↓ in cell growth, 
14-fold ↑ in p21WAF1 and 1.3-fold ↑ 
in Bax mRNA expression at 40 
mg/mL for 24 h. DNA 
fragmentation by CB extract at 40-
60 mg/mL. 
RB and STR extracts: 20-30% ↓ in 
cell growth, 5.8-fold ↑ by RB and 
3-fold ↑ by STR in p21WAF1 mRNA 
expression at 60 mg/mL.   
McDougall et al. 
2008 
Caco-2 colon 
adenocarcinoma cells 
HeLa cervical cancer 
cells 
Raspberry (RB), cloudberry 
(CB), arctic bramble (AB), 
strawberry (STR), blueberry 
(BB), and pomegranate (PG) 
extracts enriched in 
polyphenols (without sugars, 
organic acids, vitamin C and 
carotenoids) at 25, 50, and 
75 μg of GAE/mL for 72 hrs 
STR, AB, CB and RB: cell viability 
of HeLa cells ↓ (to ≤ 50% of 
control at 50 μg gallic acid 
equivalents (GAE)/mL). 
STR, AB, and CB: viability of 
CaCo-2 cells ↓ (25 μg of GAE/mL 
more effective than higher 
concentrations in Caco-2 cells). 
Mechanisms of antiproliferation 
were not studied.   
Romier et al. 
2008 
Caco-2 colon 
adenocarcinoma cells  
EA at 50 μmol/l for 24 hrs for 
the proliferation, cytotoxicity 
and nuclear factor κB 
activation assays, for 48 hrs 
for the interleukin-8 
secretion assay  
No antiproliferative or cytotoxic 
effects at 50 μM EA. 
Lipopolysaccharide-induced 
nuclear factor κB activation ↓, 
interleukin-1β induced interleukin-
8 secretion ↓; no effect on IkB-α 
phosphorylation. 
Zhang et al. 
2008 
HT-29 colon 
adenocarcinoma cells 
HCT116 colon 
carcinoma cells 
KB and CAL-27 oral 
tumour cells  
LNCaP and DU145 
prostate carcinoma 
cells 
STR extracts including ET-
rich extract and purified STR 
phenolic compounds 
including EA; extracts at 250 
μg/mL for 48 hrs, EA at 100 
μg/mL for 48 hrs   
ET-rich extract: proliferation ↓ in 
all cell lines by 30-95%. KB cells 
were the most and DU145 cells 
the least sensitive to the extract. 
EA: proliferation ↓ in all cells by 
30–80%. HCT-116 were the most 
and HT-29 the least sensitive 
cells.  
   to be continued
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Table 1 continues  
Reference Cell line(s) Berries or compounds 
studied / Study design 
Main findings: the effects of 
berry extracts and EA on 
carcinogenesis 
God et al. 2010 LoVo colon cancer 
cells 
AGS stomach cancer 
cells 
MCF-7 breast cancer 
cells  
Red raspberry extract, 
ascorbic acid only (the same 
pH and antioxidant activity), 
or HCl only (the same pH) at 
5%, 7.5%, and 10% for 48 
hrs 
LoVo and AGS: cell growth ↓; 
more effective than ascorbic acid 
only. 
MCF-7: antioxidant effect had a 
larger role in apoptosis-
independent cell killing than for 
other cells.  
Johnson et al. 
2011 
HT29 colon 
adenocarcinoma cells 
75 black raspberry (BRB) 
extracts from different 
cultivars, production sites 
and fruit maturity stages at 
0.6 and 1.2 mg/mL for 48 
hrs 
Cell growth ↓ in a dose-dependent 
manner; the higher concentration 
had cytotoxic effects. The 
antiproliferative effect was 
influenced by the horticultural 
parameters.  
Brown et al. 
2012 
HT-29 colon 
adenocarcinoma cells 
HT115 colon 
carcinoma cells 
Raspberry, strawberry, and 
blackcurrant extracts 
subjected to an in vitro 
digestion and fermentation 
process to simulate 
conditions in vivo at 0–50 
μg/ml GAE for 24 ̶ 48 hrs 
HT-29: H2O2- induced DNA 
damage ↓, faecal water-induced 
mutations ↓ 
HT115: invasion of HT115 cells in 
Matrigel invasion assay ↓   
Umesalma et al. 
2015 
HCT-15 colon 
adenocarcinoma cells 
EA at 20 ̶ 120 μM for 0  ̶48 h Cell viability ↓; cell cycle arrest; 
expressions of proliferating cell 
nuclear antigen, cyclin D1, 
phosphatidylinositol 3-kinase, 
pAKt, and Bcl-2 ↓; expressions of 
Bax, cyt c and caspase-3 ↑; DNA 
fragmentation ↑; all in a dose- 
and/or time-dependent manner.     
BERRIES: AB, arctic bramble; BB, blueberry; BlackB, blackberry; BRB, black raspberry; CB, cloudberry; PG, 
pomegranate; RB, raspberry; RRB red raspberry; STR strawberry.  
OTHER ABBREVIATIONS: EA, ellagic acid; GAE, gallic acid equivalents; HUVEC, human umbilical vein endothelial 
cells. The ↑ ↓ arrows signify the direction of the change in comparison to the respective controls.  
* If cells of tissues and organs other than gastrointestinal cells were used in a study, they have also been included in 
the table. 
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4.2 Studies in animal models      
Hitherto in vivo studies on the effects of ellagitannin-containing berries on 
experimental tumourigenesis have used black raspberries (Rubus 
occidentalis) and strawberries (Fragaria × ananassa) (reviewed in Table 2). 
Black raspberry contains moderate amounts of ellagitannins (175 mg/100 g 
dry weight; Stoner et al. 2006) but it is also a rich source of anthocyanins (381 
mg/100 g fresh weight; Scalzo et al. 2008).  Strawberry is a moderate source 
of both ellagitannins and anthocyanins (77 mg and 38 mg/100 g fresh weight; 
Koponen et al. 2007). Most of these studies have focused on oesophageal 
tumourigenesis and there are only three published studies that show the 
effects of black raspberry on intestinal (Bi et al. 2010) or colon carcinogenesis 
(Harris et al. 2001, Pan et al. 2015). These studies showed that black 
raspberry-feeding inhibited tumour development in Apc1638+/- mice by 
suppressing β-catenin signalling and in Muc2-/- mice by reducing chronic 
inflammation (Bi et al. 2010). Furthermore, black raspberry reduced the 
number and size of colonic tumours and reversed the levels of Apc-regulated 
metabolites in ApcMin mice (Pan et al. 2015). Black raspberry also reduced 
AOM-induced tumourigenesis and the concentration of urinary 8- hydroxy-2’-
deoxyguanosine, a marker of oxidative stress, in Fischer 344 rats (Harris et al. 
2001). An earlier study reported that a high concentration of ellagic acid 
reduced the number of colon adenomas in AOM-induced Fischer 344 rats (Rao 
et al. 1991). 
  
In summary, the study results reviewed in Table 2 suggest that ellagic acid and 
ellagitannin-containing berries, particularly strawberries and black 
raspberries, inhibit tumour development in the oral cavity, the oesophagus 
and the colon both in carginogen-induced and genetically modified animal 
models. The mechanisms beyond the inhibitory effects include decreased 
formation of DNA adducts, attenuated inflammatory signalling and 
angiogenesis, and restoration of gene expression dysregulated either by 
carcinogen-treatment or genetic modification.  
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Table 2. Summary of reviewed animal studies on the effects of ellagitannin and anthocyanin-
containing berries or ellagic acid (EA) on gastrointestinal carcinogenesis. All studies contained a 
control group fed a similar diet without berries or phenolic compounds. In carcinogen-induced 
models, the results are expressed in relation to the respective carcinogen-treated control group. 
All berries used were freeze-dried and powdered, and the quantities of berries in the diets are 
expressed as weight/weight (w/w) percentages.  
Reference Animal model Diets and duration of the 
feeding period in days 
and weeks 
Main findings: the effects of berries and 
EA on carcinogenesis 
Rao et al. 
1991 
F344 rats, ♂  
AOM-induced 
colon 
carcinogenesis 
AIN-76A + 4,000 or 8,000 
mg EA/kg diet  
Before, during and after 
AOM treatment 
56 wks  
8,000 mg EA/kg: number of colon 
adenomas ↓, no effect on the number of 
adenocarcinomas. Long-term dietary 
administration of EA at 2,000–8,000 mg/kg 
diet individually or in combination with other 
compounds was not toxic.  
Ahn et al. 
1996 
Fischer 344 
(F344) rats, ♂ 
Isolated 
oesophageal and 
hepatic 
microsomes were 
used for enzyme 
activity assays  
AIN-76 A + 0.4 g or 4.0 g 
EA/kg diet 
23 days  
Total P450 content in liver ↓, activities of 
certain hepatic phase II enzymes ↑. No 
remarkable changes in the expression or 
activities of oesophageal enzymes.  
Stoner et al. 
1999 
F344 rats, ♂  
NMBA-induced 
oesophageal 
tumours  
AIN-76A + 5% or 10% 
STR (containing EA 0.34 
and 0.67 mg/kg diet) 
Before, during and after 
NMBA treatment  
24 wks  
Tumour number and formation of O6-
methylguanine adducts in oesophageal 
DNA ↓ in a dose-dependent manner.  
The effect of STR was not explained by its 
EA alone. 
Carlton et al. 
2001 
F344 rats, ♂ 
Nitrosamine 
carcinogen 
(NMBA)-induced 
oesophageal 
tumours  
AIN-76A + 5% or 10% 
STR  
Before, during and after 
the NMBA treatment 
(complete carcinogenesis 
study; 32 wks) or starting 
after the 5 wks’ NMBA 
treatment (post-initiation 
study; 20 wks) or short-
term study for DNA adduct 
analyses  
5% and 10% STR: tumour number ↓ both in 
the complete carcinogenesis study and in 
the post-initiation study; in the latter, 5% 
was more effective than 10%. Formation of 
O6-methylguanine adducts in oesophageal 
DNA ↓by both STR concentrations. 
Harris et al. 
2001 
F344 rats, ♂  
Azoxymethane 
(AOM)-induced 
aberrant crypt foci 
and colon tumours 
AIN-76A + 0, 2.5, 5, or 
10% BRB  
9 or 33 wks after AOM 
treatment  
2.5, 5, and 10% BRB: ACF number ↓, 
tumour number ↓, concentration of urinary 
8- hydroxy-2’-deoxyguanosine ↓. 10% BRB: 
number of adenocarcinomas ↓.  
Kresty et al. 
2001 
F344 rats, ♂  
NMBA-induced 
oesophageal 
tumours  
AIN-76A + 5 or 10% BRB  
Anti-initiation: before, 
during and after NMBA 
treatment for 30 wks 
Post-initiation: after NMBA 
treatment for 15, 25 and 
35 wks  
5 and 10% BRB in anti-initiation assay: 
tumour number ↓.  
5 and 10% BRB in post-initiation assay: at 
25 wks, tumour incidence ↓, tumour number 
↓, proliferation rates and preneoplastic 
lesion development ↓. At 35 wks: 5% BRB 
only reduced these parameters.  
to be continued 
 
Experimental evidence of ellagitannin and anthocyanin-containing berries in gastrointestinal 
cancer chemoprevention 
28 
Table 2 continues: Summary of reviewed animal studies on the effects of ellagitannin and 
anthocyanin-containing berries or ellagic acid (EA) on gastrointestinal carcinogenesis.  
Reference Animal model Diets and duration of the 
feeding period in days 
and weeks 
Main findings: the effects of berries and 
EA on carcinogenesis 
Chen et al. 
2006a 
F344 rats, ♂  
NMBA-induced 
oesophageal 
tumours 
AIN-76A + 5% BRB  
9, 15 and 25 wks after 
NMBA treatment  
Tumour number ↓, mRNA and protein 
expressions of iNOS, COX-2, and c-Jun ↓ at 
25 wks. Activities of iNOS and COX-2 ↓.  
Chen et al. 
2006b 
F344 rats, ♂  
NMBA-induced 
tumours from the 
study of Chen et 
al. (2006a) above 
AIN-76A + 5% BRB  
9, 15 and 25 wks after 
NMBA treatment (Chen et 
al. 2006a)  
Vascular endothelial growth factor (VEGF) 
mRNA expression ↓, microvessel density of 
oesophagus ↓. Correlation between the 
expression levels of VEGF, COX-2 and 
iNOS.  
Lechner et 
al. 2008 
F344 rats, ♂  
No carcinogenic or 
genetic 
modification 
AIN76-A + 5% BRB  
3 wks 
Modification of the expression of 36 genes 
in the rat oesophagus; some of them were 
associated with cancer mechanisms. 
Stoner et al. 
2008 
F344 rats, ♂  
Short-term NMBA-
induction of 
oesophageal 
carcinogenesis  
Sacrificed 24 h 
after the last 
injection 
AIN-76A + 5% BRB / 5 
μmol phenylethyl 
isothiocyanate (PEITC) 
2 wks before and during 
the one week’s NMBA 
treatment  
Dysregulation of expression of 2,261 genes 
by NMBA. Restoration of expression of 
1,323 genes by PEITC and 462 genes by 
BRB to near-normal level. The 53 genes 
common to PEITC and BRB were involved 
in phase I and II metabolism, oxidative 
damage, apoptosis, cell cycling, and 
angiogenesis. 
Bi et al. 
2010 
Apc 1638+/- and 
Muc2-/- mice 
Intestinal 
tumourigenesis 
Western-style diet (WD) + 
10% BRB  
12 wks 
Tumour incidence ↓, tumour number ↓, cell 
proliferation ↓ in both mouse strains; β-
catenin expression ↓ in Apc 1638+/- mice, 
expression of COX-2 and inflammatory 
cytokines ↓ in Muc2-/- mice 
Stoner et al. 
2010 
F344 rats, ♂  
NMBA-induced 
oesophageal 
tumours  
AIN-76A + 5% BRB / red 
raspberry / blueberry / 
STR  
30 wks after NMBA 
treatment  
All berries: tumour incidence and number 
equally ↓, serum interleukin-5 and GRO/KC 
(rat homologue for human interleukin-8) ↓. 
Serum IFNγ ↑ by BRB (richest in ETs). 
Umesalma 
and 
Sudhandiran 
2010a, 
2010b, 
2011; 
Umesalma 
et al. 2014 
Wistar rats, ♂ 
DMH-induced 
colon 
carcinogenesis 
EA 60 mg/kg body weight 
once daily; orally in water, 
and commercial pellet diet 
After DMH treatment, for 
15 wks 
2010a: Number of ACFs ↓, number of 
crypts/ACF ↓, level of lipid peroxidation in 
colon tissue and plasma ↓, activities of 
antioxidant enzymes, reduced glutathione, 
vitamin E, and vitamin C ↑ in colon. 
2010b: Expression of inflammatory 
mediators NFκB, iNOS, COX-2, TNF-α, and 
interleukin-6 ↓.  
2011: Apoptosis ↑: expressions of PI3K, 
pAKT, and Bcl-2 ↓, and expressions of Bax, 
caspase-3 and cytochrome c ↑.   
2014: Proliferation ↓ (argyrophilic nucleolar 
organizing regions, AgNOR ↓, PCNA 
positive nuclei ↓), cyclin D1 expression ↓, 
mast cells ↓, glycoproteins in colon tissue ↓, 
expression of matrix metalloproteins MMP-2 
and MMP-9 ↓, p53 expression ↑, activities of 
phase I enzymes ↓ and phase II enzymes ↑ 
 to be continued  
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Table 2 continues  
Reference Animal model Diets and duration of the 
feeding period in days 
and weeks 
Main findings: the effects of berries and 
EA on carcinogenesis 
Wang et al. 
2010 
F344 rats, ♂ 
NMBA-induced 
oesophageal 
tumours  
AIN-76A + 5% or 10% 
BRB / STR / BB  
ET-rich residues from 
equal amounts of berries 
Before, during and after 
NMBA treatment 
30 wks 
Berries and berry residues: tumour number 
↓ equally. 10% berry diets: tumour volume 
slightly more ↓ than diets with berry residues 
or 5% berries. ET concentration of diets was 
not associated with chemopreventive 
effects.  
Wang et al. 
2011b 
F344 rats, ♂  
NMBA-induced 
oesophageal 
tumours  
AIN-76A + 5% BRB  
35 wks after NMBA 
treatment 
Tumour number and size ↓. Dysregulation of 
expression of numerous genes by NMBA; 
restoration of expression levels of many 
genes towards control levels by BRB in 
preneoplastic oesophagus and tumours. 
The NMBA-induced upregulation of Ki-67, 
CD45, CD34, and MMP10 ↓ by BRB. Bcl-
2/Bax ratio, COX-2, and VEGF expressions 
↓, expression of p27 ↑.  
Casto et al. 
2013 
Syrian Golden 
Hamsters, ♂  
7,12-
dimethylbenz(a)-
anthracene 
(DMBA) induced 
oral 
tumourigenesis 
AIN-76A + 5% or 10% 
STR  
Before, during, and after 
(complete 
chemoprevention 
bioassay) DMBA 
treatment or after DMBA 
treatment only (post-
initiation 
chemoprevention) 
All feeding periods for 12 
wks after DMBA treatment 
5% and 10% STR: number of oral lesions ↓ 
in complete and post-initiation 
chemoprevention bioassays. 5% STR 
modulated the expression of genes related 
to tumour development in post-initiation 
study. 
Pan et al. 
2015 
ApcMin and wild-
type (WT) mice 
ApcMin mice fed with AIN-
76A with or without 5% 
BRB  
WT-mice fed with AIN-76A 
for 8 wks 
Number and size of intestinal and colonic 
tumours ↓. The Apc gene mutation changed 
and BRB-feeding reversed the levels of 
several metabolites involved in amino acid, 
glutathione, lipid and nucleotide metabolism 
in the colonic mucosa, liver and faeces. 
BERRIES: BB, blueberry; BRB, black raspberry; STR strawberry. 
OTHER ABBREVIATIONS: ACF, aberrant crypt foci; AOM, azoxymethane; COX-2, cyclooxygenase; DMBA, 7,12-
dimethylbenz(a)anthracene; IFNγ, interferon gamma; iNOS, inducible nitric oxide synthase; NMBA, N-
nitrosomethylbenzylamine; TNF-α, tumour necrosis factor α; PEITC, phenylethyl isothiocyanate; PI3K, 
phosphatidylinositol 3-kinase; VEGF, vascular endothelial growth factor.  The ↑ ↓ arrows signify the direction of the 
change in comparison to the respective controls. 
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4.3 Human studies 
Only a few clinical studies on the effects of ellagitannin-containing berries on 
human gastrointestinal cancers have been published. In colorectal cancer 
patients, 60 g of freeze-dried black raspberries per day for four weeks 
decreased the methylation of tumour suppressor genes and protectively 
changed the expression of proteins related to cell proliferation, apoptosis, 
angiogenesis, and Wnt pathway (Wang et al. 2011a). The same study found 
that black raspberry treatment increased the plasma concentration of 
granulocyte macrophage colony stimulating factor (GM-CSF), which can 
activate the immune response against tumours (Jinushi et al. 2009). 
Furthermore, black raspberry decreased the concentration of pro-
inflammatory IL-8, and modulated the markers of proliferation, apoptosis, 
and angiogenesis in adenocarcinomas and adjacent normal-appearing tissue 
into the protective direction (Mentor-Marcel et al. 2012). Two daily rectal 
suppositories of black raspberry (each containing 720 mg black raspberry 
powder) administered to familial adenomatous polyposis (FAP) patients for 
nine months significantly decreased the burden but not the number of rectal 
polyps. However, no additional benefit was seen when the rectal suppositories 
were combined with 60 g of orally administered freeze-dried black raspberries 
per day for nine months. Black raspberry also decreased the expression of 
DNA methyltransferase 1 expression and p16 promoter methylation in rectal 
polyps (Wang et al. 2014a). 
 
The protective effects of black raspberries and strawberries on preneoplastic 
lesions of the oesophagus and oral cavity have also been reported. Freeze-dried 
black raspberries, 32 g for females or 45 g for males, administered to Barrett’s 
oesophagus patients once a day for 26 weeks reduced urinary excretion of 8-
iso-prostaglandin F2α, a marker of lipid peroxidation, and increased the 
expression of GST-pi, a marker of detoxification, in Barrett´s oesophagus 
epithelium (Kresty et al. 2016).  In patients with dysplastic lesions of the 
oesophagus, 60 g of freeze-dried strawberries daily for six months inhibited 
the progression of precancerous growth. The berry treatment reduced the 
histological grade of lesions, inhibited the protein expression of iNOS, COX-2, 
NF-κB, pS6, and inhibited cell proliferation. However, the smaller dose (30 
g/day) did not affect the grade of lesions or any of the measured parameters 
(Chen et al. 2012). A 10% (w/w) freeze-dried black raspberry gel applied four 
times daily for six weeks modified gene expression, decreased the level of 
COX-2 protein and reduced loss of heterozygosity (LOH) in the oral 
intraepithelial neoplasia in patients with premalignant oral intraepithelial 
lesions (Mallery et al. 2008, Shumway et al. 2008). The same dosage of gel for 
three months decreased the lesion size and histopathological grade, and 
reduced the LOH events in the oral intraepithelial lesions (Mallery et al. 2014). 
In summary, black raspberries and strawberries are suggested to inhibit 
carcinogenesis in the colon, the oesophagus, and the oral cavity in human 
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subjects by regulating the expression of genes and proteins related to cell 
proliferation, apoptosis, angiogenesis, and inflammatory response both in the 
tumours and the adjacent normal-appearing tissue. 
4.4 Pomegranate, its ellagitannins and their microbial 
metabolites urolithins 
Pomegranate (Punica granatum) is the most familiar and widely studied 
source of ellagitannins, and the interested readers are directed to a recent 
review on its effects on colorectal cancer chemoprevention (Núñez-Sánchez et 
al. 2015a). Briefly, both pomegranate ellagitannins and their metabolites, the 
urolithins, inhibit cell proliferation and induce apoptosis in several colorectal 
cancer cell lines (Larrosa et al. 2006, Seeram et al. 2005, González-Sarrías et 
al. 2009, González-Sarrías et al. 2014, Kasimsetty et al. 2010). Pomegranate 
extract, juice, and peel extract inhibit carcinogen-induced colon 
tumourigenesis in rodent models (Sadik et al. 2013, Banerjee et al. 2013, 
Boateng et al. 2007, Waly et al. 2012, Waly et al. 2014). Free ellagic acid and 
its conjugates, gallic acid and 12 urolithin derivatives were found in colon 
tissues of colorectal cancer patients that had consumed 900 mg pomegranate 
extracts per day for 15 days before surgical resection. Interestingly, the 
concentrations of all metabolites were higher in the normal colonic tissue than 
in the malignant tissue (Nuñez-Sánchez et al. 2014). The same trial found that 
the intake of pomegranate extract changed the expression of micro-RNAs 
(miRNA) both in malignant and normal colonic tissues. Even though the 
regulated miRNAs targeted cancer-related genes, no association was found 
between the tissue urolithins and the changes in the miRNA expression 
(Nuñez-Sánchez et al. 2015b).  
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5 Proposed mechanisms of ellagitannin-
containing berries and their compounds 
in colon cancer prevention 
The mechanisms that mediate the chemopreventive effects of berries, berry 
extracts, and their compounds have been studied for decades, but they are still 
not known in detail. The effects of ellagic acid have been investigated since 
1982, when its antimutagenic activity was shown (Wood et al. 1982). The early 
studies that followed the Wood group’s study were focused on the ability of 
ellagic acid to inhibit metabolic activation of carcinogens by inhibiting 
cytochrome P450 enzymes, inducing certain phase II enzymes, and interfering 
in the binding of carcinogen metabolites to DNA (Ahn et al. 1996). Thereafter, 
berries, berry extracts and their compounds have been shown to inhibit 
carcinogenesis through numerous mechanisms and the role of gut microbiota 
in mediating their effects has also been found to be important. Both human 
and animal studies have shown that the composition of gut microbiota is 
associated with the colorectal carcinogenesis (Borges-Canha et al. 2015, 
Irrazábal et al. 2014, Schwabe and Jobin 2013). Furthermore, diet is known to 
modulate the composition of gut microbiota (David et al. 2014, Salonen and 
de Vos 2014, Walker et al. 2011), and dietary sources of ellagitannins have also 
been found to affect gut microbes both in vitro and in vivo (Li et al. 2015a and 
2015b, Puupponen Pimiä et al. 2013). The effects of ellagitannins and their 
dietary sources on the gut microbiota are described here first, followed by 
other effects. 
5.1 Gut microbiota 
Cloudberry, raspberry and their ellagitannins have antimicrobial activities and 
they selectively inhibited the growth of Gram-negative bacteria, such as the 
intestinal pathogen Salmonella enterica, but not the Gram-positive probiotic 
lactic acid bacteria in vitro (Puupponen-Pimiä et al. 2001, 2005). 
Pomegranate juice by-product and punicalagins inhibited the growth in vitro 
of the pathogenic Clostridium species and S. aureus, but had no or only a 
slightly inhibiting effect on the growth of lactobacilli, and even enhanced the 
growth of some bifidobacteria (Bialonska et al. 2009). Another study showed 
that pomegranate juice and extract increased the growth of lactobacilli and 
bifidobacteria, but inhibited the growth of B. fragilis group, clostridia, and 
Enterobacteriaceae in a dose-response manner in vitro, and may thus be able 
to act as potential prebiotics (Li et al. 2015).  
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Pomegranate juice by-product rich in gallic acid oligomers, ellagic acid, and 
glucose increased the total number of bacteria, the number of Bifidobacterium 
ssp. and the Lactobacillus-Enterococcus group, and the concentrations of 
short chain fatty acids in a fermentation system that simulated the human 
colon and was inoculated with samples of human faeces. However, the same 
treatment in the same set up did not affect the growth of the Clostridium 
coccoides-Eubacterium rectale group and the potentially harmful C. 
histolyticum group. In contrast, punicalagins alone had no effect on the 
growth of bacteria or production of short chain fatty acids (Bialonska et al. 
2010). Pomegranate extract (250 mg/kg body weight/day) or its main 
metabolite urolithin A (15 mg/kg body weight/day) in diet of Fisher rats 
increased the number of faecal bifidobacteria, lactobacilli and Clostridium 
spp. (Larrosa et al. 2010). The number of caecal Bifidobacterium ssp. was also 
increased in Balb/c mice fed with a high-fat diet supplemented with 
pomegranate peel extract (6 mg/day/mouse) in comparison to control mice 
(Neyrinck et al. 2013).  
 
Human subjects can be stratified into urolithin producers and non-producers 
as indicated by the findings of intervention studies. Of healthy subjects, 60 ̶ 
80% belong to phenotype A that produce only urolithin A, 10 ̶ 30% to 
phenotype B that produce isourolithin A and/or urolithin B in addition to 
urolithin A, and 5 ̶ 15% to phenotype 0 that have no urolithin production 
(Tomás-Barberan et al. 2014). This inter-individual variability can affect the 
outcome of intervention studies and should be considered when analyzing the 
results. Li et al. (2015) found that both the baseline gut microbiota and the 
changes induced by daily intake of 1000 mg pomegranate extract for four 
weeks were different in urolithin producers and non-producers; e.g. the 
phylum Firmicutes was decreased and Proteobacteria increased in urolithin 
producers but not in non-producers after the four weeks’ intervention. In 
addition, pomegranate extract consumption enhanced urolithin A production 
in producers and induced production in some but not in all non-producers (Li 
et al. 2015). Another study found that an intake of 200 ml/day of pomegranate 
juice (containing 880 mg ellagic acid and ellagitannins) for four weeks 
increased the faecal concentrations of urolithin A and other phenolic 
metabolites, but did not change the composition of gut microbiota (Mosele et 
al. 2015). Furthermore, no differences were found in the diversity of faecal 
predominant bacterial populations of human subjects after a daily intake of 
strawberries, raspberries and cloudberries containing 790 mg ellagitannins or 
a diet with practically no ellagitannins for eight weeks. However, predominant 
bacterial profiles changed in four out of 20 subjects in the berry group, and 
two of these subjects did not produce urolithins at baseline but the production 
of urolithins was induced during the period of berry supplementation 
(Puupponen-Pimiä et al. 2013). 
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In summary, dietary ellagitannins modulate the metabolism of phenolic 
compounds in the gut and can alter the composition of gut microbiota. The 
latter occurs as a consequence of antimicrobial and prebiotic effects. 
Ellagitannins, and other polyphenols, promote the growth of lactobacilli and 
bifidobacteria, and thus act as prebiotics (Dueñas et al. 2015). These changes 
in gut microbiota are suggested to decrease the production of genotoxic 
compounds and increase the concentrations of bioavailable phenolic 
metabolites.  
5.2 Anti-genotoxic effects  
Carcinogenesis is initiated by mutations in genes that are associated with cell 
proliferation, differentiation and apoptosis, and ellagitannin-containing berry 
extracts have been found to protect cells from genotoxic effects in vitro. Since 
berry extracts and single berry polyphenols are potent antioxidants in vitro 
(Skrovankova et al. 2015), their anti-genotoxic effects may be at least partly 
due to their antioxidant activity. Raspberry polyphenols that were digested in 
in vitro conditions inhibited H2O2-induced DNA damage in HT-29 cells 
(Coates et al. 2007). Moreover, digested and then fermented raspberry and 
strawberry extracts decreased both faecal water and H2O2-induced genotoxic 
effects in the same cell line (Brown et al. 2012). The feeding of black raspberry 
to azoxymethane-treated Fischer 344 rats decreased the number of aberrant 
crypt foci and total number of tumours, and it also reduced the concentration 
of urinary 8-hydroxy-2’-deoxyguanosine (Harris et al. 2001), which is a widely 
used biomarker for endogenous oxidative DNA damage (Valavanidis et al. 
2009). However, the antioxidant capacity of a compound or an extract does 
not always correlate with its anti-carcinogenic or antiproliferative activity (Liu 
et al. 2002, Meyers et al. 2003); and not all the strong antioxidants are strong 
anti-carcinogenic agents, and vice versa (Wang et al. 2013). 
  
Berry compounds have also been suggested to selectively bind to DNA and 
thus block DNA methylation and enhance the repair of pro-mutagenic 
adducts. For example, black raspberry feeding before the treatment with N-
nitrosomethylbenzylamine carcinogen inhibited the formation of the pro-
mutagenic O6-methylguanine adducts in the rat oesophagus, even though it 
did not affect the metabolism of N-nitrosomethylbenzylamine (Kresty et al. 
2001).   
5.3 Cell proliferation, apoptosis and invasive growth 
All functions in normal cells are strictly regulated by numerous signalling 
pathways, whereas this control is lost in cancer cells as the result of mutations 
and/or epigenetic modifications in DNA. Dysregulated expression and 
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activation of proteins that regulate cell proliferation, differentiation, and 
apoptosis lead to the uncontrolled growth and formation of neoplastic tissue 
(Hanahan and Weinberg 2000, 2011). Proliferation, and differentiation, and 
all other steps in the life cycle of cell, are regulated by many factors including 
cell cycle proteins, signal transduction pathways, conditions in the cell 
microenvironment, and cell metabolism (Hanahan and Weinberg 2000, 
2011). Apoptosis can be induced or blocked by factors that regulate either the 
extrinsic or intrinsic apoptosis pathway (Kiraz et al. 2016). Alterations in some 
or all of these factors accumulate in cells as they change from normal to 
malignant phenotype.  
 
Polyphenolic compounds including ellagitannins have been suggested to 
prevent carcinogenesis by inhibiting the alterations associated with 
uncontrolled proliferation (Feitelson et al. 2015) and by inducing apoptosis 
(Cho et al. 2015, González-Sarrías et al. 2016, Kasimsetty et al. 2010, Larrosa 
et al. 2006, Seeram et al. 2005 and 2006a). The antiproliferative effects of 
ellagitannins may also be due to their anti-inflammatory effects on the colon 
mucosa (Adams et al. 2006, Banerjee et al. 2013, Kim et al. 2016, Marín et al. 
2013). In addition, a few studies have shown that ellagic acid and ellagitannins 
may prevent invasive growth by inhibiting angiogenesis (Ceci et al. 2016, 
Kowshik et al. 2014, Labrecque et al. 2005, Lee and Lee 2005, Sartippour et 
al. 2008, Wang et al. 2012b, Wang et al. 2014b, Zhao et al. 2013) and cancer 
cell migration (Ceci et al. 2016, Gu et al. 2016, Ko 2015, Ko et al. 2015, Rocha 
et al. 2012, Wang et al. 2012a, Pitchakarn et al. 2013) in several cancer types. 
However, there is only one study that reports indirect effects of ellagic acid on 
angiogenesis in an ex vivo colon cancer model (Haraguchi et al. 2014) and 
another study investigated the effects of ellagic acid on colon cancer cell 
migration (Losso et al. 2004). The hallmarks of cancer presented by Hanahan 
and Weinberg (2000, 2011) that were suggested to be influenced by 
ellagitannin-containing berry extracts, ellagic acid, ellagitannins, and their 
metabolites in colon cancer models are summarized in Figure 4. 
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Figure 4.  Hallmarks of cancer, 10 biological capabilities acquired during the tumour 
development, are represented by the rectangles. The hallmarks that are reported to 
be inhibited by ellagitannin-containing berry extracts, ellagic acid, ellagitannins, and 
their metabolites in colon cancer models according to the literature published so far 
are shown in grey shading. The figure is modified from that shown in the article by 
Hanahan and Weinberg (2011). 
Anti-proliferative effects  
Cell cycle, a process including replication of DNA in the S (synthesis) phase 
and cell division in the M (mitosis) phase, is driven by complexes of cyclin-
dependent kinases (CDK) and cyclins. Its normal progress is assessed at 
checkpoints G1 before the S phase, G2 before the M phase, and at spindle 
assembly checkpoint at the M phase. In normal cells, the cell cycle arrest at the 
abovementioned checkpoints allows cells to repair possible defects in DNA 
synthesis and chromosome segregation, whereas in mutated and tumour cells 
a resulting dysregulated cell cycle leads to continuous and uncontrolled cell 
proliferation (Malumbres and Barbacid 2009). However, several studies have 
shown that ellagitannin-containing berry extracts, ellagitannins, and ellagic 
acid inhibit cell proliferation in colon tumour cells (Johnson et al. 2011, God 
et al. 2010, Katsube et al. 2003, Larrosa et al. 2006, Losso et al. 2004, Olsson 
et al. 2004, Olsson et al. 2006, Seeram et al. 2006, Wu et al. 2007, Zhang et 
al. 2008). A few studies that investigated the underlying mechanisms suggest 
that the antiproliferative effects were due to the cell cycle arrest and changes 
in the expression of cell cycle proteins (Coates et al. 2007, Larrosa et al. 2006, 
Umesalma et al. 2015). Raspberry polyphenols that had been digested in in 
vitro conditions induced cell cycle arrest in the G1 phase in HT-29 colon 
adenocarcinoma cells (Coates et al. 2007), whereas ellagic acid, punicalagin, 
alone, or in any combination induced cell cycle arrest in the S phase and 
decreased the expression of cyclins A and B1 in Caco-2 cells. However, the 
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increase in the expression of cyclin E was not in line with the findings 
mentioned above (Larrosa et al. 2006). In another study, ellagic acid induced 
cell cycle arrest in the G2/M phase and downregulated the expression of cyclin 
D1 and proliferating cell nuclear antigen (PCNA), a widely recognized 
proliferation marker, in HCT-15 colon adenocarcinoma cells (Umesalma et al. 
2015). Ellagic acid (60 mg/kg body weight orally in water) also decreased the 
cyclin D1 expression and the number of PCNA-positive nuclei in the colon 
tissue of DMH-treated Wistar rats (Umesalma et al. 2014). The 
antiproliferative effects of cloudberry, strawberry, and raspberry extracts in 
HT-29 colon adenocarcinoma cells were associated with increased mRNA 
expression of CDK1/2 inhibitor p21Cip1/Waf1, but the concentrations of berry 
extracts in cell culture medium were not physiologically relevant (Wu et al. 
2007). 
 
Pro-apoptotic effects 
The chemopreventive effects of ellagitannin-containing berries, ellagitannins, 
and ellagic acid have also been suggested to be due to the induction of 
programmed cell death, apoptosis. In Caco-2 cells, ellagic acid, punicalagin, 
and mixture of them decreased the expression of anti-apoptotic Bcl-xL and 
activated caspase-9 and caspase-3, thus inducing apoptosis by intrinsic 
pathway. The observed effect on apoptosis was specific to Caco-2 cells and was 
not detected in CCD-112CoN normal colon fibroblasts (Larrosa et al. 2006). 
Umesalma et al. (2011, 2015) found similar pro-apoptotic effects by ellagic 
acid both in HCT-15 colon adenocarcinoma cells in vitro and in the colon 
tissue of DMH-induced Wistar rats in vivo, which showed increased 
expression of Bax, caspase-3 and cytochrome c, and decreased expression of 
Bcl-2. All these changes indicated activation of the intrinsic apoptotic 
pathway, which was suggested to be a result of inhibited PI3K/Akt pathway 
(Umesalma et al. 2011, 2015). Increased Bax expression and DNA 
fragmentation were also found in Caco-2 cells treated with cloudberry extract, 
but the concentration of extract (40 ̶ 60 mg/mL) was far from a physiologically 
relevant concentration (Wu et al. 2007). 
 
Invasive growth  
Invasive growth is characterised by angiogenesis, tumour-promoting 
inflammation and cancer cell migration. Angiogenesis, the formation of new 
capillaries, is essential for tumour growth. When the diameter of a solid 
tumour exceeds two millimetres, new vasculature is required to provide the 
tumour with oxygen and nutrients (Bergers and Benjamin 2003). Vascular 
endothelial growth factor (VEGF) is regarded an important angiogenesis 
factor during carcinogenesis and tumour metastasis (Goel and Mercurio 
2013). Ellagic acid has been found to inhibit angiogenesis by the VEGF 
pathway in several cancer types both in vivo and in vitro (Ceci et al. 2016, 
Kowshik et al. 2014, Labrecque et al. 2005, Wang et al. 2012b, Zhao et al. 
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2013). However, there is only one published study on the effects of ellagic acid 
on angiogenesis in colon cancer, in that study Haraguchi et al. (2014) reported 
that dietary ellagic acid elevated caecal succinate level, which in turn inihibited 
angiogenesis in an ex vivo angiogenesis assay. Moreover, a black raspberry 
diet (5% w/w) was found to downregulate VEGF mRNA expression and 
microvessel density in the oesophagus of NMBA-treated rats, which probably 
resulted from decreased expressions of COX-2 and iNOS (Chen et al. 
2006a,2006b).  
 
Inflammation is characteristic of invasive growth, but it is already present in 
the initiation phase of carcinogenesis (Elinav et al. 2013) and is associated 
with increased colorectal cancer risk, such as in individuals with inflammatory 
bowel disease (Sebastian et al. 2014) and obesity (Divella et al. 2016). 
Compounds with immunomodulatory and anti-inflammatory properties, 
including ellagitannins, can therefore inhibit carcinogenesis by attenuating 
pro-inflammatory signalling (Adams et al. 2006, Banerjee et al. 2013, Marín 
et al. 2013, Shi et al. 2015, Umesalma et al. 2010). Anti-inflammatory effects 
of ellagic acid and ellagitannins may be mediated by inhibition of transcription 
factor nuclear kappa B (NF-κB) and mitogen-activated protein kinase (MAPK) 
signalling pathways, but also through the mammalian target of rapamycin 
(mTOR) pathway, which all have key roles in inflammatory response (Kim et 
al. 2016, Romier et al. 2009).  
 
Ellagic acid inhibited lipopolysaccharide-stimulated NF-κB activity in Caco-2 
cells, and also reduced interleukin (IL) 1β-induced secretion of IL-8 (Romier 
et al. 2008). Pomegranate extract also inhibited cytokine-stimulated NF-κB 
and ERK1/2 activities in Caco-2 cells, and decreased the synthesis of nitric 
oxide, IL-8, and prostaglandin E2, probably through the NF-κB pathway 
(Romier-Crouzet et al. 2009). The feeding of black raspberry decreased the 
number and incidence of intestinal tumours in addition to the mRNA 
expression of COX-2 and proinflammatory cytokines in Muc2-/- mice, a widely 
used rodent model of chronic intestinal inflammation (Bi et al. 2010).  
 
Cancer cell migration is one of the essential prerequisites to tumour 
progression and metastasis, and there are a few studies, which show that 
ellagic acid and ellagitannins inhibit migration in prostate cancer cells both in 
vitro (Pitchakarn et al. 2013, Wang et al. 2012a) and in vivo (Wang et al. 
2014b), and in breast cancer cells in vitro (Rocha et al. 2012).  There are 
hitherto no published studies that investigate the migration of colon cancer 
cells. However, the hepatocyte growth factor (HGF)-Met signalling pathway 
essential for cancer cell migration and an important target in the research for 
cancer treatments has been suggested to be involved in cancer cell migration 
in intestinal epithelial tissues.    
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6 Objectives of this study 
The overall aim of this thesis was to study the chemopreventive effects of 
cloudberry on intestinal tumourigenesis in experimental models. The specific 
objectives were set during the progression of the studies as follows: 
 
1) The first objective was to study, whether cloudberry and bilberry prevent 
tumour formation in ApcMin mice. 
2) The cloudberry effectively reduced both the number and size of intestinal 
tumours in ApcMin mice. The next aim, therefore, was to reveal whether 
cloudberry pulp and seeds have distinct effects on tumour formation in 
ApcMin mice. The effects of pure ellagic acid, which mimics the content of 
ellagitannins and ellagic acid in the cloudberry diet were also studied. 
3) Both cloudberry and bilberry decreased the number of intestinal tumours 
in ApcMin mice, but only cloudberry reduced the tumour size. The next 
objective was to study the molecular mechanisms behind the different 
effects of cloudberry and bilberry. The research focused on the effects of 
the berries on the gut microbiota, intestinal immunity, and mucosal 
global gene expression. 
4) Cloudberry inhibited the first two steps of carcinogenesis in ApcMin mice, 
thus the following objective was to study the effects of cloudberry on the 
indicators of cancer progression, particularly cancer cell migration and 
underlying cell signalling in human adenocarcinoma cell lines.  
5) Because cloudberry inhibited Met signalling in human adenocarcinoma 
cells, the last aim in this research series was to ascertain whether 
cloudberry feeding had affected Met signalling in tumours of ApcMin mice. 
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7 Study designs, materials and methods 
7.1 Study designs and diets in animal studies (I-IV) 
C57BL/6J ApcMin mice, which carry a heterozygous Apc mutation and 
spontaneously develop intestinal tumours after spontaneous loss of the wild-
type allele (Moser et al. 1995), were used to study the effects of berries on 
intestinal carcinogenesis. The mice (n=10-12/group) were fed experimental 
diets for 10 weeks. All diets were modified high-fat, non-fibre AIN93-G diets 
(Reeves et al. 1993) which had 41% of their energy from fat, 39% from 
carbohydrates, and 19% from protein. The composition and content of fat 
approximated to that in a typical Western-type diet and provided the intake of 
saturated, monounsaturated and polyunsaturated fatty acids in the ratio of 
3:2:1. The compositions of diets in Studies I-IV relevant for this thesis are 
presented in Tables 3 and 4. 
 
Studies I, II and IV  
Experimental diets were prepared by adding 10% (w:w) freeze-dried berries to 
the modified high-fat AIN93-G diet, and the control diet was of a similar 
formulation to the berry treatment diet but without the berries (Table 3). The 
compositions of diets were designed so that the contents of carbohydrate, 
protein and fat were equal in both berry diets and in the control diet. Berries 
were obtained from Kiantama Oy (Suomussalmi, Finland), freeze-dried and 
ground. The texture of the diets was homogeneous apart from the cloudberry 
diet that contained whole cloudberry seeds. The polyphenol concentrations in 
the diets were calculated using the values that were obtained from the freeze-
dried berries and are shown in Table 5.  The methods used were described 
earlier (Määttä-Riihinen et al. 2004a, 2004b). The daily food consumption of 
a mouse was estimated to be 2.5 g/mouse/day, thus the calculated total intake 
of ellagitannins and free ellagic acid in the cloudberry group was 3.9 mg ellagic 
acid equivalents/mouse/day. Correspondingly, the total intake of 
anthocyanins was 13.8 mg/mouse/day and the intake of flavonols 0.26 
mg/mouse/day in the bilberry group. 
  
Study III 
Cloudberry was found to be by far the most chemopreventive berry in Study I 
and the seeds made up nearly half of the freeze-dried cloudberries, therefore 
the effects of the components of cloudberry on adenoma formation were 
studied separately. The diets in Study III contained either cloudberry seeds, 
cloudberry pulp or pure ellagic acid (Table 5). The control diet without the 
berry components was similar to that formulated and used in Study I. 
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Cloudberries were obtained from Kiantama Oy (Suomussalmi, Finland), 
freeze-dried and ground before the seeds and pulp were separated from each 
other by sieving. The freeze-dried cloudberries were found to contain 47% 
(w/w) seeds and 53% (w/w) pulp. The same concentrations of seeds and pulp 
in the separate diets in comparison to the whole-cloudberry diet in Study I 
were formulated by adding 4.7% (w/w) seeds and 5.3% (w/w) pulp to the 
corresponding diets. Contents of ellagitannins and free ellagic acid in the 
cloudberry seeds and pulp were analysed as described previously (Häkkinen 
et al. 2000, Määttä-Riihinen et al. 2004b) and their concentrations in the diets 
were calculated based on the analysed values. The concentrations of 
ellagitannins and free ellagic acid in the seed diet were 807 and 42 mg/kg, and 
in the pulp diet 820 and 34 mg/kg, respectively. The calculated intakes of 
ellagitannins and free ellagic acid were 2.0 and 0.11 mg/mouse/day in the seed 
group and 2.1 and 0.08 mg/mouse/day in the pulp group and they were based 
on the estimated food consumption of 2.5 g/mouse/day. Pure ellagic acid 
(Sigma E-2250; Sigma-Aldrich Co., St. Louis, MO, USA) was added to the diet 
at 1565 mg/kg of diet, equal to its concentration in the 10% (w/w) whole-
cloudberry diet in Study I, and the mean intake of pure ellagic acid was 3.9 
mg/mouse/day. The composition of diets in Study III are presented in Table 
4.  
 
Table 3. Composition of treatment and control diets (g/kg diet) fed in Studies I, II and IV. 
Ingredient Control diet a 
g/kg 
Cloudberry diet b 
g/kg  
Bilberry diet c 
g/kg  
Freeze-dried berry, containing 
   Anthocyanins (mg)* 
   Flavonols (mg)** 
   Total ellagic acid (mg)***    
 
100  
0 
2 
1564 
100  
5532 
104 
0 
Casein 236.2 217.8 220.7 
Dextrose 479 412.6 413.2 
Butter 148.9 142.5 141.1 
Sunflower oil 13.3 9.8 8.8 
Rapeseed oil 62.2 59.5 59.0 
Mineral mix AIN-93-MX 41.6 39.8 39.4 
Vitamin mix AIN-93-VX 11.8 11.3 11.2 
L-cystine 3.6 3.4 3.4 
Cholinechloride 3.6 3.4 3.4 
Tert-butylhydroxyquinone 0.014 0.014 0.014 
a Control diet was a high-fat, non-fibre modification of the AIN-93G diet (Reeves et al. 1993). 
The b cloudberry and c bilberry diets were modified from the a control diet by the addition of cloudberry, 
or the reference bilberry. Addition of berries was compensated for by decreasing the amounts of other 
ingredients in the diets and taking into account the amounts of energy nutrients in berries. 
*, **, *** mg/100 g freeze-dried berries and thus in a kg of diet  
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Table 4. Composition of treatment and control diets (g/kg diet) in Study III (CB, cloudberry; EA, 
ellagic acid). 
Ingredient Control diet a 
g/kg 
CB seed diet b 
g/kg 
CB pulp diet c 
g/kg 
EA diet d 
g/kg 
Cloudberry seeds 
Cloudberry pulp 
Ellagitannins from berry 
components (mg)*  
 
Free ellagic acid from berry 
components (mg)** 
 
Ellagic acid, mg  
(Sigma E-2250)  
 
 
46.6 
 
807 
 
 
42 
 
 
53.4 
820 
 
 
34 
 
 
 
 
 
 
 
 
1564 
Casein 236.2 222.6 229.4 235.8 
Dextrose 479.0 459.2 440.7 478.3 
Butter 148.9 142.7 144.6 148.7 
Sunflower oil 13.3 11.4 12.9 13.3 
Rapeseed oil 62.2 59.6 60.4 62.1 
Mineral mix AIN-93-MX 41.6 39.9 40.4 41.5 
Vitamin mix AIN-93-VX 11.8 11.3 11.5 11.8 
L-cystine 3.6 3.5 3.5 3.6 
Cholinechloride 3.6 3.5 3.5 3.6 
Tert-butylhydroxyquinone 0.014 0.013 0.013 0.014 
a Control diet was a high-fat, non-fibre modification of the AIN-93G diet (Reeves et al. 1993). 
The b cloudberry (CB) seed, c cloudberry pulp and d ellagic acid diets were modified from the a control 
diet. Addition of cloudberry seeds or pulp was compensated for by decreasing the amounts of other 
ingredients and taking into account the amounts of energy nutrients in cloudberry components. 
d Ellagic acid diet was modified from the a control diet. The addition of ellagic acid was compensated for 
by decreasing the amounts of other ingredients. 
*, ** mg from the amount of cloudberry seeds or pulp added to a kg of diet 
 
  
 43 
Table 5. Concentrations (mg/100g) of phenolic compounds in freeze-dried cloudberries and 
bilberries incorporated into the diets fed in Studies I, II and IV. 
Phenolic compound Cloudberry 
mg/100g 
Bilberry 
mg/100g 
Total anthocyanins, including - 5532 
Delphinidin glycosides - 1717 
Cyanidin glycosides - 1818 
Petunidin glycosides - 840 
Peonidin glycosides - 462 
Malvidin glycosides - 695 
Total flavonols, including 2 104 
Quercetin glycosides 2 90 
Myricetin glycosides - 14 
Total ellagic acid b 1564 0 
* ellagitannins and unconjugated (free) ellagic acid 
7.1.1 ApcMin mice 
 
The study protocols were approved by the Laboratory Animal Ethics 
Committee of the University of Helsinki. Male and female C57BL/6J Min/+ 
(ApcMin) mice were bred at the Experimental Animal Unit of the University of 
Helsinki from inbred mice that had been originally obtained from the Jackson 
Laboratory (Bar Harbor, ME, USA). The mice were genotyped by using a PCR 
assay for the Apc alleles (Dietrich et al. 1993). At the age of five weeks, the mice 
were stratified by litter and sex and assigned randomly to the control or 
experimental diets in 10 ̶ 12 mice per group. The duration of the feeding period 
was 10 weeks. The mice were housed in plastic cages in a temperature and 
humidity controlled animal facility, with 12-h light/dark cycle, and they had 
free access to a semisynthetic diet and tap water. Body weights and general 
welfare of the animals were recorded weekly. Mice that had a considerable loss 
of weight were sacrificed before the end of the feeding period and excluded 
from the analysis. The mice that were originally fed for Study I were also used 
in Studies II and IV. The final number of mice that were used in the analyses 
were 10 in the control group, 11 in the cloudberry group, and 12 in the bilberry 
group. Only the data and tissues from the control and cloudberry-fed mice 
were used in Study IV. The total number of mice in Study III was 47 (control 
11, cloudberry seed 12, cloudberry pulp 12, and ellagic acid 12 mice). 
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7.1.2 Tumour scoring and sample collection 
 
At the end of the feeding period mice were killed by CO2 asphyxiation. The 
small intestine, caecum and colon were removed immediately. The small 
intestine was divided into five sections, opened longitudinally, rinsed with ice-
cold isotonic saline and placed flat on objective glasses. The colon and caecum 
were kept together but were otherwise treated identically to the small 
intestine. The number, diameter, and location of adenomas were determined 
microscopically at a magnification of x 67.  
 
Samples (7 mm) were taken from the distal end of the middle section of the 
small intestine, and fixed in buffered 4% formaldehyde solution overnight and 
embedded in paraffin for immunohistochemical analyses. The mucosa 
samples for RNA extraction were taken from the most distal section of the 
small intestine, namely the ileum. Sampling took place immediately after the 
tissue was confirmed to be free of any tumours and kept in RNA stabilization 
reagent (Qiagen) until isolation. Small diameter (≤1 mm) and large diameter 
(≥1.1 mm) adenomas were excised, collected separately according to the size 
category, snap frozen in liquid nitrogen and stored in −70°C for protein 
extraction and Western blot analyses in Study IV. Caecum contents for PCR-
DGGE analysis in Study II were collected and frozen immediately at −70°C. 
 
7.2 Study design and cloudberry extract in cell culture 
studies (IV)  
Two human colon adenocarcinoma cell lines, HT29 cells that carry two 
mutated APC alleles and HCA7 cells with wild type APC alleles, were used to 
study the effects of cloudberry extract on cell migration and cell signalling in 
vitro. Cell migration was studied in scattering and wound healing assays both 
with and without hepatocyte growth factor (HGF) induction (Potempa et al. 
1998, Mataraza et al. 2003). Cells were cultured at 37°C in a 5% CO2 
atmosphere in Dulbecco's Modified Eagle's medium (Gibco-Invitrogen) 
supplemented with 10% foetal calf serum, penicillin and streptomycin. For all 
experiments in Study IV, cells were seeded on fibronectin-coated (10 μg/mL) 
tissue culture dishes. Cells were incubated for 48 ̶ 72 h before time-lapse 
microscopy for the cell scattering experiments, and allowed to grow to 100% 
confluence for the wound healing experiments. The concentration of 
cloudberry extract (5 μL/mL cell culture medium) was chosen based on 
preliminary experiments and it did not result in a reduction in cell numbers 
nor did it induce cell necrosis. Two independent preparations of cloudberry 
extract were used in Study IV. 
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7.2.1 Composition of cloudberry extract 
 
Cloudberry extract was prepared by crushing six grams of freeze-dried 
cloudberries (including the seeds and peels) and extracting it with methanol 
that was removed by rotary evaporation after centrifugation at 3500g for 10 
min. The dried sample was then reconstituted in 4.5 mL of Milli-Q water and 
frozen. The phenolic profile of cloudberry extract was determined using 
Waters ACQUITY ultra performance liquid chromatography (UPLC) as 
described by Kylli et al. (2011) and the phenolic compounds were identified 
according to their UV spectra. Based on the results of these analyses, 
cloudberry extract that was added to the cell culture medium (5 μL/mL) 
provided final concentrations of 36.3 μg/ml ellagitannins, 19.1 μg/ml 
flavanols, 8.8 μg/ml hydroxycinnamic acids, 5.9 μg/ml hydroxybenzoic acids, 
and 5.3 ug/ml ellagic acid, but only 1.2 μg/ml flavonols and 0.02 μg/ml 
anthocyanins in cell culture medium. 
7.2.2 Cell culture and migration studies 
 
Both HGF-induced and intrinsic (i.e. without HGF-induction) cell migration 
in human HT29 and HCA7 colon adenocarcinoma cell lines were studied by 
cell scattering and wound healing experiments as described in detail in the 
original article of Study IV. Cells were treated either with 40 ng/mL HGF or 
HGF together with 5 μL/mL of cloudberry extract in growth medium.  
 
Both scattering and wound healing experiments were monitored and recorded 
by time-lapse microscopy, during which cells were incubated at 37°C in a 
humidified chamber at 5% CO2. Phase-contrast images of live cells were taken 
and archived every 5 min for 16 hours with Tempus software (Andor 
Technology, Belfast, UK), using a KPM1E/K-S10 CCD camera (Hitachi, 
Denshi, Japan) mounted on an Axiovert microscope using a 20X 
Plan/Neofluar objective (Zeiss).  
 
Wound healing images were analysed quantitatively at various time points by 
determining the percentage of remaining wound area as compared to the area 
of the wound at the first time point (baseline). The wound area at each time 
point was measured with the geodesic active contours (Caselles et al. 1997) by 
setting a few initial circular contours in the middle of the wound, and making 
the contours iteratively propagate to fill the whole wound area. The scatter 
area evolution was measured as the wound area except that only the single 
initial contour that included whole scatter area was used. The contour was 
subsequently made to iteratively contract after which the area was defined as 
a combination of all isolated contours generated during the contractions of the 
initial contour. All contours were included in area analyses at all the time 
points as these merged into one larger area during the experiment. All 
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processing was carried out with BioImageXD software, an open access, high-
throughput image-processing computer platform (Kankaanpää et al. 2012). 
7.3 Methods 
7.3.1 Immunohistochemical stainings  
 
Immunohistochemical stainings are described in detail in the original 
publications of Studies II and IV. Briefly, serial 5 μm sections of samples were 
deparaffinized and subjected to heat-induced antigen retrieval in a microwave 
oven. Specific staining protocols and markers were used to analyze T and B 
lymphocytes, regulatory T cells, Met, and pMet; the marker CD3ε (clone SP7, 
RM-9107; NeoMarkers, Fremont, CA) was used for T lymphocytes, FoxP3 
(clone FJK16s, 14-5773; eBioscience, San Diego, CA) for regulatory T cells, 
CD45R (clone RA3-6B2, RM2600; Invitrogen, Waltham, MA) for B 
lymphocytes, c-Met ab59884 for Met, and c-Met ab5662 (phospho Y1230 + 
Y1234 + Y1235) for pMet (both Met antibodies from Abcam, Cambridge, UK). 
The immunostained sections were photographed using a Leica DM4000 
microscope (Wetzlar, Germany) and an Olympus DP70 camera (Tokyo, 
Japan). The densities of intraepithelial and mucosal lymphocytes in the digital 
photomicrographs were analysed using ImageJ software (Schneider et al. 
2012). The intensity and localization of Met and pMet expression in adenoma 
tissue were analysed by visual inspection.   
7.3.2 Analysis of bacterial diversity in mice caecum samples  
 
Bacterial genomic DNA was extracted from cecum contents using the FastDNA 
Spin kit for Soil (QBiogene, USA) and the V6 and V8 regions of the bacterial 
16S rDNA were amplified as previously described (Mättö et al. 2005).  PCR 
products were separated in polyacrylamide gels with denaturating gradient as 
described in the original publication of Study II. The gels were stained with 
SYBR Green, visualized in UV light and photographed. The profiles were 
compared by calculating the similarity percentage using BioNumerics 
software version 5.1 (Applied Maths BVBA, Belgium). Clustering was 
performed using the Pearson correlation and the unweighted-pair group 
method (UPGMA). Amplicons with the total surface area of at least 1% were 
included in the similarity analysis. In addition, evolutionary modelling was 
performed using a maximum parsimony tree with a bootstrap value 100. 
 
The amplification product characteristic for the bilberry-fed mice (“band g”, 
Fig. 3B in the original publication of Study II) was excised from the gel and the 
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DNA was obtained for re-amplification with the same primer pair as 
previously described.  Amplification product was purified and sequenced as 
described in the original publication of Study II. Sequence was analysed with 
ABI PRISM 3100 capillary DNA cycle sequencer (Applied Biosystems) and 
checked and edited with the Chromas program (Technelysium, Australia). The 
sequence was identified through the GenBank database 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) and deposited there with the 
accession number KP257583. 
7.3.3 RNA isolation and the Affymetrix microarray 
 
Total RNA was extracted from the mucosa of each animal in Study I by using 
the RNeasy Mini kit (Qiagen). Equal amounts of total RNA from 10–12 mice 
of each diet group were used to prepare 3–4 pooled RNA samples (2–4 mice 
per pool) for each group for hybridization to Affymetrix microarray, which 
enabled the measurement of the expression of a large number of genes at the 
same time. The labelling, hybridization, and scanning of the arrays were 
performed at the Centre for Biotechnology, University of Turku, Finland.  
7.3.4 Whole cell extracts, Western blot analyses and 
immunoprecipitation 
 
Protein extracts from whole cells of the HT29 and HCA7 cell lines were 
prepared to study the effects of cloudberry extract on migration-related cell 
signalling. The preparation of cell extracts and Western blot analyses are 
described in detail in the original publication of Study IV. Briefly, cells were 
cultured as described above for scattering experiments and treated either with 
HGF or HGF and cloudberry extract for the stated times. Cells were lysed on 
ice in a lysis buffer pH 7.4 solution, the lysates were clarified by centrifugation 
and protein concentrations were determined using BioRad Bradford protein 
assay reagent. Lysates were denaturated in Laemmli sample buffer, heated and 
then stored in −70°C. The proteins were separated in SDS (sodium dodecyl 
sulphate) gels and transferred to polyvinylidene difluoride membranes.  The 
membranes were blocked against non-specific binding of primary antibodies 
with bovine serum albumin (for phosphorylated AKT, pAKT, and 
phosphorylated ERK, pERK) or non-fat milk in Tris-buffered saline, and 
probed with primary antibodies as described in the original publication of 
Study IV. The proteins were detected using horseradish-peroxidase-
conjugated secondary antibody, enhanced chemiluminescence kit 
(Amersham/GE Healthcare, UK), and the images were transferred to X-ray 
films. Band intensities were determined and quantified using a GS-800 
densitometer and Quantity One software (BioRad, Hercules, CA). The 
quantities of phosphorylated and total protein of AKT and ERK were 
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determined using the same blots. After the determination of the 
phosphorylated form, the blots were stripped to remove the antibodies that 
had been used to detect the phosphorylated form to make the determination 
of total form possible. Small diameter (≤1 mm) and large diameter (≥1.1 mm) 
adenomas of the control and cloudberry-fed ApcMin mice in Study I were 
analysed for pAKT, AKT, pERK, and ERK in the same way. 
 
The effects of cloudberry extract on the activation of receptor Met were studied 
by immunoprecipitation and Western blotting for tyrosine phosphorylation. 
Cells were cultured, treated either with HGF or HGF and cloudberry extract 
and then lysed as described above and in the original publication of Study IV. 
Proteins from the lysates were incubated with anti-Met antibody conjugated 
to protein A/G PLUS-agarose and centrifuged to collect the pellets, which were 
re-suspended in denaturating sample buffer and analysed for tyrosine 
phosphorylation and total Met levels by Western blotting. The blots were 
developed and the bands quantified as described above. 
7.3.5 Statistical analyses 
 
The distributions between the groups of the adenoma data, 
immunohistochemical staining scores, and Western blot results from in vivo 
studies were tested for statistical significance by the Mann-Whitney U-test. 
The relations between adenoma and immunohistochemical staining data were 
tested by Spearman correlation, and the relations between adenoma and 
bacterial profile data by Pearson correlation. Male and female mice were 
pooled in the analyses since there were no differences in the number and size 
of adenomas between the sexes. Non-parametric tests were used due to the 
small number of samples (n=10 ̶ 12 per group) and differences were considered 
significant for p-values below 0.05. 
 
The Affymetrix data were normalized by using the GC-Robust Multichip 
Average algorithm and analysed by one-way ANOVA using the GeneSpring 
software (Agilent Technologies Inc., Palo Alto, CA, USA) with a cut-off value 
of P<0.05. In Study I, genes with a 2-fold or more increase or decrease in 
expression in a berry-group in comparison to the control group for all 
replicates in each group were tested using the Student’s t test. In Study II, the 
genes that exceeded the 1.2-fold change limit between the control and either 
of the berry-fed groups were considered as candidates for being regulated 
genes. Statistics described above were used to detect the enriched GO 
functional categories (http://geneontology.org/) or KEGG pathways 
(http://www.genome.jp/kegg/) associated with the genes. This procedure 
diminishes the effect of false positives, as only a large body of genes with 
similar functions will show as significant enrichment. Differences in gene 
expression results were considered significant at P<0.05.   
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In Study IV, differences of standardized wound and scatter-data behaviour in 
treatment groups (HGF vs. HGF + cloudberry) over time were compared with 
parametric ANCOVA (group*time) interaction terms.  The binary presence of 
HGF and type of cell (HCA7 and HT29) was also used as a stratifying variable, 
or as a group variable instead of the cloudberry treatment in the analyses.  
 
Statistical analyses were carried out using StatView 5.0.1 software (SAS 
Institute Inc., Cary, NC) and PASW 18.0.1 (SPSS Inc., 2009, Chicago, IL). 
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8 Results 
This section gives an overview on the effects of feeding whole cloudberry, its 
components, or bilberry on intestinal adenoma development. It also reports 
the effects of cloudberry and bilberry-feeding on intestinal immune response, 
gut microbiota and global gene expression in ApcMin mice. The effects of 
cloudberry extract on cancer cell migration and cell signalling in human HT29 
and HCA7 colon adenocarcinoma cells are also presented. More detailed 
results are given in the original publications enclosed in this thesis. The results 
of the effects of three berries (cloudberry, bilberry and lingonberry) on tumour 
formation and cell signalling in Study I have been thoroughly discussed in the 
original paper and in the PhD thesis of Marjo Misikangas (Misikangas 2007). 
This dissertation is focused on the different effects of cloudberry and bilberry. 
8.1 Cloudberry, but not its components, reduced tumour 
development in ApcMin mice (I, III)      
In Study I, the diet containing 10% (w/w) freeze-dried cloudberries decreased 
the number (P<0.05) and size (P<0.01) of adenomas in the whole small 
intestine when compared to the control diet. Bilberries also decreased the 
number (P<0.05) of adenomas but increased the size (P<0.05) of them in the 
whole small intestine (Fig. 5). The inhibitory effect of cloudberry on the 
adenoma growth was associated with the decreased expression of nuclear 
cyclin D1 (P<0.01 when compared to the control diet) and a non-significant 
decrease in nuclear β-catenin (P=0.065) in the large diameter (≥1.1 mm) 
adenomas. 
  
In Study III, the cloudberry was divided into seeds and pulp, which were fed 
to separate groups of ApcMin mice. The concentration of seeds or pulp in the 
diet were equal to the whole-cloudberry diet in Study I, but the total 
concentrations of ellagitannins/ellagic acid in the diets were a bit less than half 
of their concentration in the previous whole-cloudberry diet. No differences 
between the cloudberry seed, pulp or pure ellagic acid-fed groups and the 
control group were found in the number of adenomas in the whole small 
intestine (Fig. 5). These diets had no effect on the mean adenoma size in the 
whole small intestine either (Fig. 3A in the original publication). However, the 
ellagic acid group had larger adenomas (mean diameter 1.50 ± 0.29 mm) in 
the duodenum than the control group (1.16 ± 0.31 mm; P=0.029; Fig. 3B in 
the original publication). 
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Figure 5.  The number (A, B) and size (C, D) of adenomas in the whole small intestine of 
ApcMin mice fed with a control diet without any added berries or diets containing 
10% (w/w) freeze-dried cloudberries or bilberries in Study I (A, C), or 10% (w/w) 
freeze-dried cloudberry (CB) seeds, cloudberry pulp or 1564 mg/kg ellagic acid in 
Study III (B, D). The boxes represent the interquartile ranges (IQRs) and therefore 
contain 50% of the values. The median is indicated by the horizontal line across 
each box and the whiskers above and below the box extend to the maximum and 
minimum values. 
8.2 Cloudberry-feeding attenuated intestinal cell-mediated 
immunity in ApcMin mice (II) 
The effects of cloudberry and bilberry-feeding on intestinal immunity in 
ApcMin mice were compared with the control-fed group. The proportion of the 
intraepithelial to total mucosal CD3+ T lymphocytes was smaller in the 
cloudberry group than in the control group (Study II; Fig. 2A in the original 
publication; P<0.05), and there was a positive correlation (P<0.05) between 
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the total adenoma burden and the proportion of intraepithelial CD3+ T 
lymphocytes in the small intestine (Study II; Fig. 2B in the original 
publication). The mean proportion of FoxP3+ T lymphocytes to total CD3+ T 
lymphocytes in the intestinal mucosa was also slightly but non-significantly 
smaller in the cloudberry group than in the control group (Study II; Fig. 2C in 
the original publication) and a significant correlation (P<0.05) was found 
between the FoxP3+/CD3+ ratio and the total adenoma burden in the small 
intestine (Study II; Fig. 2D in the original publication). Neither feeding whole 
cloudberry nor whole bilberry modulated the density of mucosal B 
lymphocytes, and interestingly, the bilberries had no effect on the density of 
any lymphocytes in the intestinal mucosa.  
8.3 Cloudberry and bilberry-feeding affected gut microbiota 
differently in ApcMin mice (II) 
The predominant bacterial diversity (Study II, Fig. 3 in the original 
publication) was significantly smaller in the cloudberry group (35.5 ± 2.8) and 
in the control group (33.3 ± 2.7) as compared to the bilberry group (41.0 ± 5.8; 
P<0.05). Moreover, the caecal samples from the mice that had the smallest 
adenoma sizes clustered together and were obtained from the cloudberry-fed 
mice (Study II; Fig. 5 in the original publication). In addition, a particular band 
(‘g’; Study II; Fig. 3 in the original publication) was weak or missing in the 
samples of cloudberry and control groups, but more prevalent and intense in 
the samples of the bilberry group. Sequencing followed by a BLAST search 
showed that the g-band was closest to the type strain of Clostridium aldenese 
RMA 9741 (identity 91%), whereas an uncultured bacterium clone abc22d07 
(Sequence ID: gb|AY668073.2|) from mouse caecal sample was a complete 
match. The RDPII search found the closest type strain was Blautia producta 
ATCC 27340 (identity 90%). 
8.4 Cloudberry and bilberry-feeding modulated global 
mucosal gene expression in ApcMin mice (I, II)  
An Affymetrix microarray assay was carried out to find potential differences in 
the intestinal mucosa at the gene expression level. One-way ANOVA of Study 
I data indicated diet-induced changes in the expression of 377 genes. The 
expression of 11 genes in the bilberry group and 10 genes in the cloudberry 
group differed from the control group at the cut-off point of 2-fold difference 
between the berry and control groups (Study I; Supplemental Table 2 in the 
original publication of Study I). The expression of adenosine deaminase and 
5’-ectonucleoditase were consistently and similarly decreased by both the 
berries. The expression of many genes that encode immunoglobulins was also 
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changed. Therefore, the effects of berry-feeding on the intestinal immune 
response were studied further in Study II, and the gene expression data were 
analysed using gene enrichment analyses. For this purpose, the cut-off point 
was set at 1.2-fold change between the control and the berry groups, which 
revealed 16 up-regulated and 32 down-regulated genes for the cloudberry-
added diet only. Moreover, 183 other genes were up-regulated and 56 down-
regulated exclusively for the bilberry-added diet. Four genes were differently 
regulated by the two berries. Only one of these genes, the gene that encodes 
for phosphoenolpyruvate carboxykinase 1 (Pck1), was down-regulated by 
cloudberry and up-regulated by bilberry. Conversely, three other genes were 
up-regulated by cloudberry and down-regulated by bilberry, but the functions 
of these genes are not known yet (Fig. 6). 
 
Figure 6.  The expression of 183 genes were up-regulated (green) and 56 down-regulated 
(blue) by bilberry; the expression of 16 genes were up-regulated (orange) and 32 
down-regulated (light pink) by cloudberry. The gene that encodes for 
phosphoenolpyruvate carboxykinase 1 (Pck1; grey) was down-regulated by 
cloudberry and up-regulated by bilberry; the expression of three genes (turquoise) 
were down-regulated by bilberry and up-regulated by cloudberry. The expression of 
69 genes were up-regulated (brown) and the expression of 70 genes down-
regulated (pink) by both berries. Analyses were made using 3 ̶ 4 pooled RNA 
samples from 10 ̶ 12 mice of each diet group. Comparisons were made to the 
control group and differences were considered significant at P<0.05 (ANOVA). 
No KEGG pathways were enriched in the cloudberry group but eight KEGG 
pathways were enriched in the bilberry group. Bilberry increased the 
expression of many mitochondrial genes and consequently up-regulated four 
KEGG pathways related to oxidative phosphorylation. KEGG pathways for 
glycolysis/gluconeogenesis, glutathione metabolism and drug metabolism 
were also up-regulated by the bilberry enriched diet (Study II; Table 2 in the 
original publication). 
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Only three GO biological processes (GO-BP), all related to carbohydrate and 
energy metabolism, were enriched in the cloudberry group, whereas 36 GO-
BPs were enriched in the bilberry group (Study II; Tables 3 and 4 in the 
original publication). The berries had opposite effects on the expression of 
energy metabolism-related genes and the differences were also seen in the 
enrichment of biological processes: cloudberry down-regulated and bilberry 
up-regulated GO-BPs related to energy metabolism. 
 
In addition, as shown in Figure 6, the expression of 69 genes was up-regulated 
and the expression of 70 genes down-regulated by both berries. Consequently, 
one KEGG pathway (Huntington’s disease) and 29 GO-BPs were shared 
between the berries; twenty of them were related to immunological processes 
and referred to attenuated antibody-dependent immunity (Study II; Table 6 in 
the original publication). Huntington’s disease pathway included 13 genes, 
nine of which were associated with the electron transport chain and oxidative 
phosphorylation. This suggests that genes associated with oxidative 
phosphorylation were up-regulated by both berries, whereas those related to 
glycolysis and gluconeogenesis were up-regulated by bilberry only. 
8.5 Cloudberry extract inhibited the migration of HT29 and 
HCA7 cells (IV) 
The figures referred under the 8.5–8.8 inclusive are shown in the original 
publication of Study IV. 
  
Cloudberry extract inhibited HGF-induced cell migration in both the HT29 
and HCA7 cell lines. The scattering experiments showed that the increase in 
scatter area after 15 hours of the HGF treatment was 53 percentage points 
smaller in cloudberry treated HCA7 cells than in HCA7 control cells (Study IV, 
Fig. 1C; HGF vs. HGF+Cloudberry P<0.001). The scratch wound healing assay 
showed that cloudberry extract significantly inhibited HGF-induced wound 
healing in both cell lines (Study IV, Fig. 3C and 3D; in both P<0.001). Without 
HGF stimulation, cloudberry extract inhibited scratch wound healing in HT29 
cells (Fig. 3E) but not in the HCA7 cells (Fig. 3F).  
8.6 Cloudberry extract changed the cell signalling in HT29 
and HCA7 cells (IV) 
HGF stimulation of the HT29 and HCA7 cells led to the sustained activation 
of AKT and ERK, both of which increased rapidly after the addition of HGF, 
then reached a maximum level after 1–4 h, which subsequently gradually 
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decreased to nearly basal levels (Fig. 4A). The use of PI3K and MEK1 inhibitors 
confirmed that HGF-induced scratch wound closure and scattering in HT29 
and HCA7 cells were dependent on the activation of PI3K and MAPK pathways 
(see Fig. 4B and 4C for HT29 cells). Cloudberry extract inhibited HGF-induced 
phosphorylation of AKT and ERK in HT29 cells (P=0.03 for pAKT/AKT; 
P=0.05 for pERK/ERK; Fig. 5B and 5C) and in HCA7 cells (P<0.001 for 
pAKT/AKT; P=0.018 for pERK/ERK; Fig. 5E and 5F), and the inhibitory effect 
of cloudberry extract on HGF-induced motility was therefore accompanied by 
the downregulation of PI3K and MAPK pathways. 
   
Finally, cloudberry extract was shown to inhibit HGF-induced motility of 
HT29 and HCA7 by directly inhibiting the activation of their respective Met 
receptors. HGF treatment induced tyrosine phosphorylation of Met, but this 
was inhibited by cloudberry extract as assessed by the reduction in pMet/Met 
levels in HT29 (Fig. 6A and 6B; P=0.004) and HCA7 cells (Fig. 6C and 6D in 
Paper IV; P=0.036). 
8.7 Cloudberry-feeding inhibited the AKT and ERK 
signalling in the adenomas of ApcMin mice (IV)  
Cloudberry was the most effective berry in reducing the size of adenomas in 
ApcMin mice (Figure 1; P=0.006) in Study I. The activation of AKT and ERK in 
small diameter (≤1mm) and large diameter (≥1.1 mm) adenomas of cloudberry 
fed mice and control mice were analysed separately as a part of Study IV to 
evaluate further the anti-carcinogenic mechanisms of cloudberry. The ratio of 
pAKT/AKT in large adenomas of cloudberry-fed mice was significantly 
reduced (Study IV, Fig. 7C and 7D; P=0.015) and a similar but non-significant 
trend was seen in small adenomas (Fig. 7G). However, there was no change in 
pERK and ERK levels in either the large or the small adenomas.  
8.8 Cloudberry-feeding changed the expression of Met and 
pMet in the adenoma tissue of ApcMin mice (IV) 
Total Met levels in large adenomas were analysed by Western blotting but no 
differences between the dietary groups were found. However, the variation in 
Met levels was notably smaller in the cloudberry-fed group (Study IV, Fig. 7C 
and 7F). Immunohistochemical analysis revealed a strong positive staining of 
pMet at the edge of the tumours in control-fed mice (Study IV, Fig. 8A and 8C) 
whereas the staining in cloudberry-fed mice predominantly localized in the 
crypt area of the mucosa (Figure 8D; as also observed in control mice in Fig. 
8C; Study IV), and not in the adenoma (Figure 8B; Study IV). 
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9 Discussion 
9.1 Whole-cloudberry feeding inhibited the formation of 
adenomas in ApcMin mice whereas components of 
cloudberry did not (I, III) 
The whole-cloudberry diet decreased the number and size of intestinal 
adenomas in ApcMin mice, which indicates that it efficiently inhibited both the 
initiation and promotion steps of tumourigenesis. However, when 
cloudberries were fractionated into the pulp and the seeds, their 
chemopreventive effects were lost. Pure ellagic acid at a concentration similar 
to that in the whole-cloudberry diet had no chemopreventive effects either. 
Indeed, it even increased the size of adenomas in the most proximal part of the 
small intestine. The lack of any apparent chemoprevention by the diet 
containing pure ellagic acid supports the previous studies by suggesting that 
anticarcinogenic effects of berries and their polyphenols are at least partly 
produced due to the net synergism between the different compounds. For 
example, ellagic acid in combination with quercetin or resveratrol 
synergistically reduced proliferation and induced apoptosis in the MOLT-4 
human leukemia cell line (Mertens-Talcott et al. 2003, 2005a, 2005b). 
Pomegranate juice also had a stronger antiproliferative effect than ellagic acid, 
punicalagin, or total pomegranate tannin extract in several cancer cell lines in 
vitro (Seeram et al. 2005). The chemopreventive effects of the whole-
cloudberry diet may also be due to the synergistic effects of ellagitannins and 
other compounds of cloudberry. However, the lack of apparent 
chemopreventive effects of the diets that contained either cloudberry pulp or 
seeds may also be a result of the smaller concentrations of total polyphenols 
than those found in the whole-cloudberry diet in Study I. For example, the 
ellagitannin concentrations in the cloudberry pulp and seed diets may have 
been too small to produce any detectable chemopreventive effects. Therefore, 
it seems that both sufficient concentrations of polyphenols and synergistic or 
additional effects of different compounds of berries were needed for the 
effective prevention of adenoma formation. In addition, the differences in the 
total number of adenomas between the cloudberry pulp, seed or ellagic acid 
diets and the control diet in Study III may have at least partly been lost or 
hidden due to the exceptionally large variation in the numbers of adenomas 
found between the litters and between individual mice. Inbred mouse strains 
are genetically quite homogeneous and all the mice used in the studies for this 
thesis were of the same inbred ApcMin mouse strain, thus the reason for the 
large variation of adenoma numbers observed in this study remains unknown. 
In summary, the results on the effects of whole-cloudberry are supported by 
the previous studies, which are listed and summarised in Table 2 on pages 27-
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29: other ellagitannin-containing berries at corresponding concentrations 
than used here have also been found to reduce the number and/or size of 
intestinal tumours in rodent models. Contrary to the effects found for ellagic 
acid in Study III, two previous studies have reported chemopreventive effects 
of pure ellagic acid on carcinogen-induced intestinal tumourigenesis (Rao et 
al. 1991, Umesalma et al. 2010). However, the concentration of ellagic acid in 
the diet used by Rao et al. was more than five-fold the concentration used in 
Study III. Moreover, Umesalma et al. used aberrant crypt foci and not tumours 
as an endpoint, which makes the effects difficult to compare between studies. 
 
Cloudberry effectively decreased the size of adenomas in ApcMin mice in Study 
I, whereas bilberry did not. This difference in response to the two berries may 
be due to the changed Wnt and Met-signalling in the adenomas of cloudberry-
fed mice. Even though immunohistochemical stainings revealed no changes in 
the expression of β-catenin and cyclin D1 in the normal-appearing mucosa, 
cloudberry decreased their levels in the nuclei of the large adenomas and also 
prevented the increase in their concentrations in the nuclei during the 
adenoma growth.  Western blotting would perhaps have been a more sensitive 
method to show small differences in the expression levels but due to the lack 
of tissue samples these analyses were not possible in this study. A previous 
study showed that both ellagitannin-rich extracts, ellagic acid, and its 
metabolite urolithin A, inhibited Wnt-signalling in the human embryonic 
kidney 293T cell line (Sharma et al. 2010). These findings are in accordance 
with the decreased levels of β-catenin and cyclin D1 in the large adenomas of 
cloudberry-fed ApcMin mice and suggest that the inhibition of the Wnt pathway 
in the tumours of ApcMin mice may at least partly be produced by ellagic acid 
released from cloudberry ellagitannins and by urolithins produced from 
ellagitannins by the gut microbiota. In addition, the localization of pMet 
expression was also changed by whole-cloudberry feeding; pMet was strongly 
expressed at the edge of tumours in control-fed but not in cloudberry-fed mice. 
Even though no changes in the expression levels were found by Western 
blotting analyses, the localization of pMet at the invasive front of the tumour 
is important for the tumour growth (Bradley et al. 2016, Moon et al. 2005, 
Vermeulen et al. 2010). 
9.2 Cloudberry-feeding attenuated cell-mediated intestinal 
immune response in ApcMin mice (II) 
Cloudberry feeding modulated the intestinal immunity in ApcMin mice, 
whereas bilberry feeding did not. Cloudberry decreased the proportion of the 
intraepithelial to the total mucosal CD3+ T lymphocytes, and non-significantly 
decreased the proportion of regulatory FoxP3+ T lymphocytes to total CD3+ T 
lymphocytes in the intestinal mucosa compared to the control group. The 
positive correlations between both the IEL/total CD3+ and the FoxP3+/total 
Discussion 
58 
CD3+ ratios and the total adenoma burden in the small intestine suggest that 
the attenuation of intestinal immune response was one of the mechanisms that 
participated in slowing down the adenoma growth (Study II; Fig. 2 in the 
original publication). A clear but non-significant decrease in the mean 
adenoma burden was also seen in the bilberry-fed group. It is noteworthy 
therefore that the cellular immune response differed from the control only in 
the cloudberry group and no differences in the distribution of any of the 
analysed lymphocytes were found between the bilberry and control groups. 
This indicates that the decrease in the density of intraepithelial CD3+ T 
lymphocytes or mucosal FoxP3+ T lymphocytes in the cloudberry-fed group 
was a result of cloudberry feeding per se, and not of the decreased adenoma 
burden. The attenuated intestinal cell-mediated immunity may also be 
associated with the changes in the composition of gut microbiota in the 
cloudberry-fed group. No previous studies on the effects of berries or 
polyphenols on intestinal immunity and gut microbiota have been published 
as far as the author is aware. However, a recent study in which whole grains 
were substituted for refined grains for six weeks in human subjects, found 
modest changes both in the gut microbiota and in a few indicators of immune 
response. However, the effects on intestinal immunity were not studied 
(Vanegas et al. 2017). 
9.3 Cloudberry and bilberry-feeding changed the 
composition of gut microbiota in ApcMin mice (II) 
Cloudberry-feeding changed the composition of gut microbiota and the 
changes it induced in cell signalling pathways may thus have been mediated 
by the native compounds of cloudberry or by their microbial metabolites 
produced in the colon and distal small intestine or a combination of both. The 
analyses that used the PCR-DGGE method showed that the composition of gut 
microbiota differed between the cloudberry, bilberry, and control-fed mice. In 
addition, the microbial profiles of cloudberry-fed mice clustered together and 
these mice also had the smallest adenomas of any group. Therefore, the 
changes induced in the gut microbiota by cloudberry may have participated in 
slowing down the growth of adenomas.  
 
The composition of the microbiota was analysed from the contents of the 
caecum, whereas the effects of cloudberry on the development of adenomas 
were studied in the small intestine. The small intestine is the site where most 
of the adenomas in ApcMin mice are formed. The distal part of the small 
intestine is also inhabited by gut microbes, and microbial metabolites can 
affect the epithelium of the site on which they are formed. It is also possible 
that the caecal and colonic metabolites ended up in the small intestine of the 
mice due to coprophagy of their own and/or their cagemates’ faeces and thus 
the caecum contents were re-digested by the small intestine.      
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The microbial profiles were analysed using PCR-DGGE method, which reveals 
all the bacterial species that constitute more than 1% of the total bacterial 
population in the sample that will be analysed. Even though 16S rDNA based 
pyrosequencing would have allowed a more in-depth analysis (Kemperman et 
al. 2013), the simple and cost effective PCR-DGGE method made it possible to 
analyse the samples from each mouse separately. The PCR-DGGE also enabled 
the evaluation of the influence of the treatment on the general composition of 
gut microbiota, and also the interindividual variation of the response. 
 
Berries are rich in polyphenols and also contain some fibre, of which at least 
90% in cloudberries, and 85% in bilberries is insoluble. The fibre fractions of 
cloudberry have not been analysed in detail, but bilberry contains soluble 
pectin and insoluble hemicellulose, cellulose, cuticular waxes and cutin. The 
anthocyanins in bilberry may also be enclosed in the insoluble fibre matrix 
(Aura et al. 2015). The presence of fibre may affect the fermentability of the 
polyphenols and thus the yield of their microbial metabolites (Saura-Calixto 
et al. 2010). On the other hand, the dietary polyphenols may either enhance 
(Aprikian et al. 2003) or suppress the fermentation of dietary fibre and thus 
the production of short-chain fatty acids, particularly butyrate (Bazzocco et al. 
2008). In addition, both ellagitannins and anthocyanins have been shown to 
inhibit starch degrading digestive enzymes (McDougall and Stewart 2005), 
and like tannins, they may also be able to bind  enzymes in a non-specific 
manner (Santos-Buelga and Scalbert 2000), and thus affect the amounts of 
metabolites, such as  butyrate that is produced at a site. Butyrate is an 
important source of energy for the colonic epithelial cells, and depending on 
the prevailing conditions, it may either enhance or suppress epithelial cell 
proliferation (O’Keefe 2016). 
 
The changes in the gut microbiota found in this study may have been induced 
by both the polyphenols and dietary fibre contents of the berries. The fibre 
fractions of the berries and the berry components may also have affected the 
metabolism of berry polyphenols, whereas pure ellagic acid in the non-fibre 
diet was independent of these interactions. However, the total fibre content in 
the cloudberry diet was approximately 3.7% and in the bilberry diet 2.1%. 
Furthermore, the concentration of soluble, and thus fermentable, fibre was 
only 0.3% in both the cloudberry and bilberry diets. Because previous studies 
have shown that 5 ̶ 15% (w/w) content of fermentable fibre (e.g. inulin and 
oligofructose) were needed to increase the caecal butyrate content (Pool-Zobel 
2005), the soluble fibre contents in cloudberry and bilberry diets fed to the 
mice in the present study probably had no or minuscule effects on butyrate 
production, and thus they were not measured in this study. 
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9.4 Cloudberry and bilberry-feeding modified the 
expression of energy metabolism-related genes in 
ApcMin mice (II) 
Both cloudberry and bilberry-feeding modified the global gene expression in 
the intestinal mucosa of ApcMin mice. The gene expression data from an 
Affymetrix microarray assay was first analysed in Study I using the cut-off 
point of a 2-fold difference in the gene expression between the berry and 
control groups. In Study II, more detailed analyses used the cut-off point of a 
1.2-fold change difference in combination with gene enrichment analyses. 
Even though the analyses with the lower cut-off value were originally done due 
to the numerous changes in the expression of immunological genes in the 
previous analyses, the main findings from the pathway analyses were the 
changes found in the expression of energy metabolism-related genes. Among 
these, the most interesting finding was that the expression of the 
phosphoenolpyruvate carboxykinase 1 (Pck1) gene was decreased by 
cloudberries and increased by bilberries when compared with the control diet. 
The cytosolic enzyme Pck1 catalyses the formation of phosphoenolpyruvate 
from oxaloacetate, which is the main rate-controlling step of gluconeogenesis. 
The expression of glucose-6-phosphatase, which catalyses the last step of 
gluconeogenesis and glycogenolysis, was also decreased by cloudberry feeding. 
Thus, these changes in glucose metabolism in combination indicate attenuated 
glycolytic activity in the cloudberry-fed group. In contrast, the increased 
expression of Pck1 in the bilberry-fed group was associated with increased 
expression of genes for other energy metabolism-related enzymes that catalyse 
gluconeogenesis and the citric acid cycle. Even though the changes in the 
expression of individual genes are small, when taken together they could 
modulate the glycolytic activity in the intestinal mucosa, attenuating glycolysis 
in the cloudberry-fed mice and enhancing it in the bilberry-fed mice. 
  
The reprogramming of energy metabolism towards aerobic glycolysis, which 
is also known as Warburg effect (Potter et al. 2016), has been designated as a 
hallmark of cancer (Hanahan and Weinberg 2011). In a state of aerobic 
glycolysis, tumour cells start to use glycolysis in energy production, even in the 
presence of sufficient oxygen, in order to produce enough building blocks for 
proteins, lipids, and nucleotides needed for continuous cell division. Even 
though the Warburg effect has mainly been studied in fast-proliferating 
tumour cell models in vitro, the results of Study II suggest that the metabolic 
shift towards aerobic glycolysis may already happen in the normal-appearing 
mucosa of ApcMin mice and may have been prevented by cloudberry and 
promoted by bilberry.  
 
The results of this study suggest that the cloudberry diet suppressed the 
metabolic shift towards aerobic glycolysis and thus prevented the growth of 
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adenomas, whereas metabolic changes in the bilberry-fed group were the 
opposite and favoured the adenoma growth. The metabolic change in the 
bilberry-fed group is supported by the finding that lyophilized red grape 
pomace, which resembles the phenolic composition of bilberry also increased 
the activation of glycolysis and gluconeogenesis pathways in the colon mucosa 
of healthy C57BL/6J mice (Lizarraga et al. 2011).  The upregulated expression 
of the genes that code for glycolytic enzymes may indicate enhanced glycolysis 
in the intestinal mucosa, which in turn may be a link between the metabolism 
of intestinal cells and the composition of gut microbiota. It is possible that 
increased glycolysis made the microenvironment in the intestinal mucosa 
more acid and thus facilitated the growth of tumour-promoting bacteria, 
which also participated in accelerating the growth of adenomas in the bilberry 
group.  
9.5 Cloudberry extract inhibited the cell migration and 
underlying signalling pathways of HCA7 and HT29 cells 
(IV) 
The investigations done for this thesis used the ApcMin mouse strain to study 
the first two phases of carcinogenesis, initiation and promotion, whereas 
human colon adenocarcinoma cell lines were used to study the last phase, 
progression. Cell migration is a prerequisite for the progression and 
metastasis, and whole-cloudberry extract was found to inhibit cell migration 
in HT29 and HCA7 human colon adenocarcinoma cell lines. These cell lines 
differ in their status for the tumour suppressor adenomatous polyposis coli 
(APC) gene. The HT29 cells carry two mutated APC alleles, whereas HCA7 are 
wild type for APC (Ilyas et al. 1997). Both HT29 and HCA7 cells still have an 
epithelial morphology, similar levels of Met and responsiveness to HGF. Cell 
migration is stimulated by hepatocyte growth factor as determined by the 
scratch wound healing assay, which is a widely used model of cell migration in 
HGF-treated cell models (Nakamura et al. 2011). Cloudberry extract inhibited 
both HGF-induced wound healing, that is the migration, and activation of AKT 
and ERK in both cell lines. This demonstrates that HGF-induced cell 
migration in HT29 and HCA7 cells is dependent on the activation of the 
PI3K/AKT and Ras/ERK pathways, which contribute to HGF/Met-induced 
invasive growth program in cancer cells (Trusolino and Comoglio 2002). 
  
Intrinsic migration without HGF treatment was inhibited by cloudberry 
extract in APC-mutated HT29 cells only. The protein coded by the APC gene 
also has a well-known role in regulating directional cell migration in the gut 
(Nelson et al. 2012), thus further studies must be conducted to find out 
whether this difference in intrinsic cell migration by cloudberry was due to 
APC allele status or due to differences in other signalling pathways between 
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the cell lines. However, the results demonstrate that the effect of cloudberry 
on the HCA7 cells was specific to HGF-induced migration. Furthermore, 
scratch wound healing in HGF-stimulated HT29 cells with cloudberry 
treatment resembled wound healing in these cells without HGF stimulation. 
  
Cloudberry extract also inhibited HGF-induced tyrosine phosphorylation of 
Met in HT29 and HCA7 cells, which indicated that it reduced HGF-induced 
ERK and AKT activation and cell migration by directly inhibiting the activation 
of the Met receptor and thus preventing receptor signalling. It is possible that 
ellagitannins of cloudberry extract acted outside the cell and interfered with 
the binding of HGF to Met or specifically inhibited Met tyrosine kinase activity 
due to the complex molecular structure and high molecular weight of 
ellagitannins. However, previous findings of the inhibitory effect of ellagic acid 
on cell migration (Losso et al. 2004) and accumulation of ellagic acid in Caco-
2 intestinal epithelial cells (Whitley et al. 2003) indicate that it is also possible 
that free ellagic acid of cloudberry extract entered the cells and acted inside 
them, even though the concentration of free ellagic acid was only one seventh 
(14%) that of the concentration of ellagitannins in the cloudberry extract. 
However, cloudberry extract directly inhibited the HGF/Met signalling 
pathway, which is one of the major therapeutic targets in cancer treatment 
(Sierra and Tsao 2011), thus the results suggest that ellagitannins may have 
some therapeutic value in reducing cancer progression.  
9.6 Cloudberry-feeding inhibited the activation of AKT and 
altered the expression of pMet in the adenomas of 
ApcMin mice (IV)  
The cloudberry extract was found to inhibit the cell migration and Met 
signalling in colon adenocarcinoma cell lines. The aim, therefore, was to study 
whether the same effect could also be found in the preceding phase of 
carcinogenesis in the adenomas of ApcMin mice. The reduced activation of AKT 
and altered localization of active pMet that were found in large adenomas of 
ApcMin mice are consistent with the findings of the chemopreventive effects of 
cloudberry extract in HT29 and HCA7 cells. A strong positive staining of pMet 
was found at the edge of tumours in control-fed mice, whereas the staining in 
the cloudberry-fed mice predominantly localized in the crypt area of the 
mucosa, not in the adenoma (Figure 8 in the original publication of Study IV). 
This finding is in line with the effects of cloudberry extract on colon 
adenocarcinoma cells in vitro and suggests that cloudberry is likely to have a 
local effect on cellular responses relevant to cell invasion at the edge of 
tumours. This is probably more relevant for larger tumours that are beginning 
to invade the surrounding tissues, even though the trend for reduced AKT 
activation in the small adenomas indicates that these changes start in the early 
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stages of tumour development. Although Met is clearly expressed in human 
colorectal cancer (Wielenga et al. 2000), Boon et al. (2006) found no 
overexpression of Met in tumours of ApcMin mice and the Met levels in general 
were near to the detection limit in the gut of the adult ApcMin mouse. However, 
pMet and thus Met activity were not analysed by those authors (Boon et al. 
2006). The results described in the present study suggest that the inhibition 
of the Met and PI3K/AKT pathways are involved in mediating the anti-
carcinogenic effects of cloudberry both in vitro and in vivo. 
9.7 Strengths and limitations of these studies 
9.7.1 Animal studies 
 
The C57BL/6 J ApcMin mouse strain is well-documented and widely used for 
studying the effects of diet and drugs on intestinal tumourigenesis (Moser et 
al. 1990; Su et al. 1992, Fodde and Smits 2001, McCart et al. 2008, Taketo and 
Edelmann 2009). This model has been considered a suitable model for 
investigating the development of intestinal tumours due to the similarity 
between the murine Apc gene and the human APC gene; 90% of amino acids 
in the Apc/APC proteins are identical (Su et al. 1992). Intestinal tumours in 
the ApcMin mouse and colon tumours in human develop in a similar adenoma-
carcinoma sequence and are also morphologically similar (Preston et al. 
2008). However, the tumours in the conventional ApcMin mouse mainly 
develop in the small intestine, and colon tumours rarely exist. After the animal 
studies of this thesis had been completed, a novel A/J Min/+ mouse was 
established by transferring the Min/+ trait from C57BL/6J ApcMin mouse to 
mice with an A/J genetic background was published (Sødring et al. 2016). The 
C57BL/6J ApcMin mice develop a mean of 30 small intestinal tumours (Moser 
et al. 1990), and typically less than one tumour per animal in the colon (Bilger 
et al. 1996, Paulsen et al. 1997, 1999, 2001). The novel A/J Min/+ mice, on the 
other hand developed a mean of 21 small intestinal and eight colonic tumours 
between the ages of 4 and 60 weeks, even though the colonic tumours were not 
detectable before the age of 11 weeks. The conventional ApcMin mouse model 
is, however, excellent for studying the effects of diet or drugs on the initiation 
and promotion phases of intestinal carcinogenesis since the effects are seen by 
the age of 15 weeks or even earlier (Pajari et al. 2003). The novel A/J Min/+ 
mouse, on the other hand, makes it possible to study also the progression 
phase of intestinal cancer because, unlike the adenomas in the C57BL/6J 
ApcMin mice, both the small intestinal and colonic adenomas in the A/J Min/+ 
mice progress to carcinomas (Sødring et al. 2016). It would therefore be 
valuable to use this new rodent model to study the effects of cloudberry on the 
progression phase of intestinal carcinogenesis in vivo. 
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The berry content (10% w/w) in the whole-cloudberry and bilberry diets was 
relatively high and it would be nearly equivalent to the consumption of 90 
g/day of freeze-dried berries by humans. An intake of 30 ̶ 60 g/day of freeze-
dried berry powder has been used in previous studies with human subjects 
(Chen et al. 2012, Kresty et al. 2016, Wang et al. 2011a, Wang et al. 2014a). 
Even though the corresponding berry content could not be reached in the 
human diet by consuming fresh berries, the concentration was chosen since 
no previous results on the effects of cloudberries and bilberries on the 
intestinal carcinogenesis in vivo had been published before. High 
concentrations are typically used to screen potential chemopreventive agents 
and to study the underlying mechanisms. Concentrations between 2.5 ̶ 10% 
(w/w) of other berries have been used in studies with carcinogen-induced 
rodent models of oesophageal, oral, and colonic tumourigenesis (Carlton et al. 
2001, Harris et al. 2001, Kresty et al. 2001, Casto et al. 2013) and the effects 
of lower cloudberry concentrations should be studied in ApcMin mice and also 
in the novel A/J Min/+ mice. 
   
A limitation of the study is that the microbial profiles were analysed in caecal 
contents only and not the epithelium directly, where the microbes are in close 
contact with epithelial cells (Dejea et al. 2014). Mucosal microbiota would also 
be a more sensitive indicator for changes in microbial composition related to 
intestinal tumourigenesis (Mira-Pascual et al. 2015). However, the strengths 
of these current studies include the wide mechanistic approach to the effects 
of cloudberry on intestinal tumourigenesis.  
9.7.2 Cell culture studies 
 
In this study, HT29 and HCA7 human colon adenocarcinoma cells were used 
to study the effects of cloudberry extract on HGF-induced migration and 
underlying cell signalling. These are well-characterized cell lines with different 
respective status of APC gene, which represent the two main forms of genetic 
defects in colorectal cancer aetiology of chromosomal instability and 
microsatellite instability, and were thus appropriate for this study (Ilyas et al. 
1997). However, the results are limited only to these two cell lines used and 
studies using other cell lines would provide more information on the effects of 
cloudberry. It would also be important to study the effects of cloudberry 
extract on normal intestinal epithelial cells, but cell lines that represent 
normal adult gut mucosal cells were and are not available. ATCC offers cell 
lines derived from the intestine of human embryo which are claimed to be 
normal, but how well these cell lines represent mature adult gut mucosal cells 
is not clear.  
 
The cells were treated with whole-cloudberry extract, which, unlike single, 
pure polyphenolic compounds, was a mixture of all methanol-extractable 
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compounds of cloudberries that contained polyphenols and carbohydrates. 
These compounds together may have additive, synergistic, or antagonistic 
effects. In comparison to the studies on single polyphenolic compounds, the 
studies using berry extracts may provide more relevant information on the 
effects of dietary components on gut cells, although it is not possible to study 
the mechanisms of single compounds when the whole extract is given as the 
treatment. The concentrations of the tested compounds in cell cultures often 
exceed the concentrations achievable in vivo. However, the concentration of 
cloudberry extract in the cell culture medium used in this study was moderate. 
For example, the concentrations of ellagitannins (36 μg/ mL) and total 
polyphenols (77 μg/mL) were in the same range as those used in some previous 
studies (Seeram et al. 2005). There is no clinical pharmacokinetic data on the 
metabolism of cloudberry ellagitannins in the human gut and it is therefore 
difficult to estimate the accurate concentrations that could be reached in the 
colon in vivo. In addition, ellagitannins are hydrolysed to release ellagic acid 
and then metabolized to urolithins in the colon in vivo. Thus, it would be 
important to study the effects of urolithins produced from the ellagitannins of 
cloudberry extract.   
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10 Conclusions and future perspectives  
This thesis is the first study that investigated the effects of cloudberry, which 
is rich in ellagitannins, on the intestinal tumourigenesis in vivo and the 
possible molecular mechanisms that might mediate changes beyond those 
effects. This is also the first study that reports the effects of a source of 
ellagitannins on the cell migration and underlying cell signalling in human 
colon adenocarcinoma cells. 
 
The results showed that whole cloudberry, but not its tested components, 
inhibited several steps of colon cancer development, from adenoma formation 
in the ApcMin mouse to increased motility of human adenocarcinoma cells. The 
inhibitory effects of cloudberry on intestinal carcinogenesis in ApcMin mice 
were associated with the inhibition of the Wnt and Met signalling pathways, 
and the modification of intestinal gut microbiota, immune response, and 
expression of energy metabolism-related genes. The changes were found to be 
simultaneous and therefore interactions between them are possible. The 
results in ApcMin mice suggest that cloudberry consumption may reduce the 
risk of colorectal cancer and slow down the growth of colorectal adenomas, but 
long-term intervention studies in human subjects would be needed to confirm 
the results. 
 
Cloudberry extract significantly inhibited cancer cell migration in HT29 and 
HCA7 human adenocarcinoma cell lines, and cell migration is a prerequisite 
for cancer progression and metastasis. Cloudberry also directly inhibited the 
HGF/Met signalling pathway, which is one of the major therapeutic targets in 
cancer treatment. The results therefore suggest that the use of cloudberry as 
an adjuvant therapy for inter alia the secondary prevention of colon cancer is 
a topic that is worth studying. 
  
Reprogrammed energy metabolism of tumour cells was added to the second 
generation of hallmarks of cancer by Hanahan and Weinberg in 2011. They 
suggested that inhibitors of aerobic glycolysis should be one of the hot spots 
for the development of therapeutic drugs. Cloudberry was found to attenuate 
the expression of energy metabolism-related genes in normal appearing 
mucosa, therefore further studies should be conducted to address whether 
cloudberry inhibits aerobic glycolysis in those intestinal tumours that already 
have reprogrammed energy metabolism towards aerobic glycolysis. 
Constituents of cloudberry could also be studied as potential candidates for 
drug development in targeting both aerobic glycolysis and the HGF/Met 
signalling pathways.  
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